<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Anesthesia for cesarean delivery</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Anesthesia for cesarean delivery</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Anesthesia for cesarean delivery</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Heather Nixon, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lisa Leffert, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David L Hepner, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marianna Crowley, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 17, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3034529451"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Goals for anesthesia for cesarean delivery (CD) must include the comfort and safety of the parturient, and the well-being of the fetus and neonate. This topic will discuss the management of regional and general anesthesia for CD. Anesthesia for CD in patients with preeclampsia and neuraxial labor analgesia are reviewed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/94369.html" rel="external">"Anesthesia for the patient with preeclampsia", section on 'Anesthesia for cesarean delivery'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">"Neuraxial analgesia for labor and delivery (including instrumental delivery)"</a>.)</p><p></p><p class="headingAnchor" id="H2806183962"><span class="h1">PREOPERATIVE ASSESSMENT</span><span class="headingEndMark"> — </span>We agree with the American Society of Anesthesiologists (ASA) Practice Guidelines for Obstetric Anesthesia, which recommend that parturients undergoing CD should have a focused history and physical examination by an anesthesia provider [<a href="#rid1">1</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>History and physical examination</strong> – Gestational history, past medical history, allergies, and anesthetic history should be reviewed. At a minimum, the physical exam should include an assessment of the vital signs, airway, cardiac and respiratory systems, and lower back (for possible neuraxial anesthesia). For patients who will undergo a scheduled and non-urgent, non-emergency CD, adequate preoperative fasting should be verified. (See  <a class="medical medical_review" href="/z/d/html/15698.html" rel="external">"Preoperative fasting in adults", section on 'Pregnant patients'</a> and  <a class="medical medical_review" href="/z/d/html/16690.html" rel="external">"Airway management for the pregnant patient", section on 'Fasting and aspiration prophylaxis'</a>.) </p><p></p><p class="bulletIndent1">The preoperative assessment for emergency CD should be as comprehensive as time permits.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antenatal anesthesia consultation</strong> – It is reasonable to schedule an antenatal consultation with an anesthesiologist for patients at risk of complications due to preexisting conditions, even if CD is not planned. Each parturient should be viewed as a potential candidate for operative delivery during labor, possibly on an emergency basis. Some of the indications for antenatal anesthesia consultation are shown in a table  (<a class="graphic graphic_table graphicRef68666" href="/z/d/graphic/68666.html" rel="external">table 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory testing </strong>–<strong> </strong>Preoperative laboratory testing should be individualized, based on patient factors and institutional norms. Pregnant women generally have a blood type and antibody screen performed as part of routine prenatal care; repeat preoperative type and screen should be performed for patients at high risk of severe bleeding, and for those with red blood cell antibodies. Baseline hemoglobin, platelet count, and coagulation testing may be indicated for specific conditions. (See  <a class="medical medical_review" href="/z/d/html/4475.html" rel="external">"Cesarean birth: Preoperative planning and patient preparation", section on 'Laboratory testing'</a>.)</p><p></p><p class="headingAnchor" id="H1102850532"><span class="h1">PREPARATION FOR ANESTHESIA</span><span class="headingEndMark"> — </span>Preparation for anesthesia includes the administration of aspiration prophylaxis, placement of one or more intravenous (IV) catheters, and standard American Society of Anesthesiologists monitors.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Aspiration prophylaxis </strong>–<strong> </strong>The obstetric patient is at increased risk of aspiration of gastric contents, especially in cases of difficult or failed intubation, when mask ventilation may be required. Guidelines for preoperative fasting and pharmacologic aspiration prophylaxis are based on gastric physiology and expert opinion, as there is limited evidence that interventions improve outcomes. Because worse outcome may be associated with aspiration of particulate matter, acidic material, and of large volumes, goals for aspiration prophylaxis are to eliminate particulate gastric contents and to decrease the volume and acidity of stomach contents at the time of induction of anesthesia.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Preoperative fasting</strong> – Gastric emptying is not changed by pregnancy [<a href="#rid2">2-4</a>], and preoperative fasting guidelines are the same for elective CD as for other surgical procedures (ie, two hour fast for clear liquids, six hours for solids, eight hours for fatty meals). (See  <a class="medical medical_review" href="/z/d/html/15698.html" rel="external">"Preoperative fasting in adults", section on 'Pregnant patients'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pharmacologic prophylaxis</strong> – Practice varies with respect to administration of pharmacologic agents prior to scheduled and emergency CD. We agree with the American Society of Anesthesiologists Practice Guidelines for Obstetric Anesthesia, which state that the timely administration of nonparticulate antacids, H2 receptor antagonists and/or <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">metoclopramide</a> should be considered before surgical procedures (eg, CD) [<a href="#rid1">1</a>]. The guidelines for preoperative fasting from the American Society of Anesthesiologists also list proton pump inhibitors for consideration [<a href="#rid5">5</a>]. </p><p></p><p class="bulletIndent2">Options for pharmacologic prophylaxis include nonparticulate antacids (ie, <a class="drug drug_general" data-topicid="9930" href="/z/d/drug information/9930.html" rel="external">sodium citrate-citric acid</a> 30 mL orally), H2 receptor blockers (eg, <a class="drug drug_general" data-topicid="8436" href="/z/d/drug information/8436.html" rel="external">famotidine</a> 20 mg IV), proton pump inhibitors (eg, <a class="drug drug_general" data-topicid="9474" href="/z/d/drug information/9474.html" rel="external">pantoprazole</a> 40 mg IV), and prokinetic agents (eg, <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">metoclopramide</a> 10 mg IV over one to two minutes). Metoclopramide promotes stomach emptying and also increases lower esophageal sphincter tone, which may be particularly helpful in parturients who typically have lower esophageal sphincter dysfunction due to hormonal and anatomical factors. Sodium citrate and citric acid oral solution increases stomach pH immediately and for approximately one hour [<a href="#rid6">6</a>], while the other prophylactic medications require 30 to 40 minutes to be maximally effective. (See  <a class="medical medical_review" href="/z/d/html/94214.html" rel="external">"Rapid sequence induction and intubation (RSII) for anesthesia", section on 'Premedication'</a>.)</p><p></p><p class="bulletIndent2">A combination of prophylactic agents may be more effective than single medications. This was demonstrated by a meta-analysis of 22 randomized studies involving pharmacologic aspiration prophylaxis for women who had general anesthesia for CD [<a href="#rid7">7</a>]. The combined administration of antacids with H2 antagonists was more effective at reducing gastric acidity (ie, pH &lt;2.5) than antacids alone, and more effective than placebo.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Premedication </strong>–<strong> </strong>Unlike many other surgical procedures, sedatives are not generally administered as premedication prior to CD, as these medications cross the placenta and also may result in some degree of amnesia for the baby's birth. Reassurance and verbal support by the anesthesia clinician provide sufficient anxiolysis for most patients.</p><p></p><p class="bulletIndent1">However, for particularly anxious patients, premedication may be required and may be safely administered, to allow placement of a neuraxial anesthetic, or to help the patient tolerate surgery while awake with neuraxial anesthesia. In one randomized trial, the administration of <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">midazolam</a> (0.02 mg/kg IV) plus <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> (0.1 mcg/kg IV) prior to spinal anesthesia for CD resulted in similar neonatal Apgar scores, pulse oximetry, and neurobehavioral scores when compared with placebo [<a href="#rid8">8</a>]. There was also no difference in the ability of the mother to recall the birth. In our practice, a single dose of IV midazolam (1 to 2 mg) given prior to CD is often sufficient for severe maternal anxiolysis, and the addition of fentanyl is not necessary. In patients who may be particularly anxious about neuraxial placement for a planned CD, 30 to 50% <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">nitrous oxide</a> by a patient-controlled mask may be an appropriate adjunct during neuraxial placement [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>IV access </strong>–<strong> </strong>We place one 16- to 18-gauge intravenous (IV) catheter in preparation for routine elective CD. We place additional IV catheters as indicated by the risk of hemorrhage, or to allow administration of magnesium when indicated.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring </strong>–<strong> </strong>Standard American Society of Anesthesiologists monitors include pulse rate, blood pressure measurement, electrocardiography, oxygen saturation via pulse oximetry, and temperature monitoring when significant changes in body temperature are expected. If sedatives are administered, end-tidal carbon dioxide (ETCO<sub>2</sub>) should be monitored as well. </p><p></p><p class="bulletIndent1">The fetal heart rate should be documented prior to CD. If possible, laboring patients who were monitored in the labor room should continue to be monitored after transfer to the operating room when surgery is significantly delayed or when clinically indicated. (See  <a class="medical medical_review" href="/z/d/html/4475.html" rel="external">"Cesarean birth: Preoperative planning and patient preparation", section on 'Fetal heart rate monitoring'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative antibiotics</strong> – A single intravenous dose of a narrow spectrum antibiotic should be administered preoperatively within 60 minutes of incision to all women undergoing planned CD  (<a class="graphic graphic_table graphicRef87200" href="/z/d/graphic/87200.html" rel="external">table 2</a>). Choice of antibiotic and dosing are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4475.html" rel="external">"Cesarean birth: Preoperative planning and patient preparation", section on 'Antibiotic prophylaxis'</a>.) </p><p></p><p class="headingAnchor" id="H1020433898"><span class="h1">ENHANCED RECOVERY AFTER CESAREAN DELIVERY</span><span class="headingEndMark"> — </span>Enhanced recovery protocols have been developed for CD, similar to other types of surgery. Such protocols consist of multidisciplinary best practices and include components that are used throughout the perioperative period [<a href="#rid10">10-12</a>]. The optimal elements of ERAS have not been determined, and protocols are institution specific. Our ERAS protocols are similar to the enhanced recovery after cesarean (ERAC) protocol published by the Society for Obstetric Anesthesia and Perinatology [<a href="#rid13">13</a>]. Common anesthesia-related components of ERAC protocols are shown in a table  (<a class="graphic graphic_table graphicRef131694" href="/z/d/graphic/131694.html" rel="external">table 3</a>).</p><p class="headingAnchor" id="H741059322"><span class="h1">CHOICE OF ANESTHETIC TECHNIQUE</span><span class="headingEndMark"> — </span>Options for anesthesia for CD include neuraxial anesthesia (ie, spinal anesthesia, combined spinal-epidural anesthesia (CSE), and epidural anesthesia) and rarely, general anesthesia. The choice of anesthetic technique should be based on maternal and fetal status, comorbidities, expected duration and difficulty of the procedure, and the presence (or absence) of an in situ epidural or spinal catheter. If a working epidural catheter is in place, the epidural catheter is used to achieve surgical anesthesia. An overall approach to the choice of anesthetic technique for CD is shown in an algorithm  (<a class="graphic graphic_algorithm graphicRef131799" href="/z/d/graphic/131799.html" rel="external">algorithm 1</a>). (See <a class="local">'Epidural drugs for CD'</a> below and <a class="local">'Failed or inadequate neuraxial block'</a> below.) </p><p>Although not recommended for first-line use, in very rare circumstances (eg, for patients with relative or absolute contraindications to both neuraxial and general anesthesia), peripheral nerve blocks (eg, transverse abdominis plane blocks together with ilioinguinal block) have been used for anesthesia for CD [<a href="#rid14">14,15</a>]. Supplementation with sedatives, opioids, and local anesthetic infiltration by the surgeon may be required with these techniques.</p><p class="headingAnchor" id="H1401256502"><span class="h2">General versus neuraxial anesthesia</span><span class="headingEndMark"> — </span>For most patients who undergo CD, we recommend using neuraxial anesthesia (NA) rather than general anesthesia (GA). There are exceptions for which GA is more appropriate as detailed below. While maternal and neonatal outcomes are not clearly improved with NA, most patients prioritize being awake for the birth of the infant. Other theoretical advantages favor NA. NA is used for &gt;95 percent of CDs in the United States and Canada [<a href="#rid16">16</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Advantages of NA for CD </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The mother can be awake for the birth and a partner can be present.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>NA avoids the need for airway instrumentation, which may be more challenging in the parturient. (See  <a class="medical medical_review" href="/z/d/html/16690.html" rel="external">"Airway management for the pregnant patient", section on 'Incidence and consequences of airway problems'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>NA minimizes the use of systemic medication and transfer of medication to the fetus.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>NA allows the use of neuraxial opioids for postoperative analgesia, thereby minimizing the need for systemic opioids. (See  <a class="medical medical_review" href="/z/d/html/121755.html" rel="external">"Post-cesarean delivery analgesia"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Blood loss during CD may be lower with NA, though the difference is likely clinically insignificant, without a difference in transfusion [<a href="#rid17">17-19</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>NA may be associated with a reduced incidence of perioperative venous thromboembolism and surgical site infection compared with general anesthesia [<a href="#rid20">20</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>NA may be associated with a reduced risk of severe postpartum depression. In a retrospective database study including over 400,000 cesarean deliveries in the State of New York, the use of general anesthesia was associated with increased risks of postpartum depression requiring hospitalization, suicidal ideation, and self-inflicted injury [<a href="#rid21">21</a>]. However, as the circumstances requiring the choice for general anesthesia may confound these results (ie, emergency versus urgent CD, or fetal distress), further research is required to define this association.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Catheter techniques</strong> – We use catheter NA techniques (ie, CSE, epidural, dural puncture epidural) rather than single-shot spinal when there is time to perform the procedure and achieve surgical anesthesia, in the following scenarios:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Expected prolonged surgery, due to complicated repeat CD, previous abdominal or uterine surgery, multiple procedures planned, high risk of hemorrhage, severe patient obesity, or cesarean hysterectomy</p><p class="bulletIndent2"><span class="glyph">•</span>Patients with increased risks for general anesthesia (eg, predicted difficult airway, history of malignant hyperthermia, prior complications from general anesthesia, full stomach)</p><p class="bulletIndent2"><span class="glyph">•</span>Patients with prior or expected difficult neuraxial techniques, or in those that the spinal technique proves to be difficult to perform</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General anesthesia</strong> – General anesthesia may be indicated for CD in the following scenarios:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Emergency CD, with insufficient time to perform neuraxial anesthesia or to achieve a surgical level of anesthesia via labor epidural catheter [<a href="#rid22">22</a>]</p><p class="bulletIndent2"><span class="glyph">•</span>Maternal refusal of, or inability to cooperate with, neuraxial anesthesia</p><p class="bulletIndent2"><span class="glyph">•</span>Failed neuraxial technique (see <a class="local">'Failed or inadequate neuraxial block'</a> below)</p><p class="bulletIndent2"><span class="glyph">•</span>Anticipated massive hemorrhage or highly complex surgery (see  <a class="medical medical_review" href="/z/d/html/94367.html" rel="external">"Anesthesia for the patient with peripartum hemorrhage", section on 'General concerns'</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Some maternal cardiac comorbidities (see  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Relative or absolute contraindications to NA (eg, coagulopathy, severe hypovolemia, infection at the site of epidural or spinal placement, some intracranial pathology) (see  <a class="medical medical_review" href="/z/d/html/89517.html" rel="external">"Overview of neuraxial anesthesia", section on 'Preoperative evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/107587.html" rel="external">"Obstetric and nonobstetric anesthesia for patients with neurologic disorders", section on 'Choice of analgesic or anesthetic technique'</a>) </p><p></p><p class="bulletIndent1">For urgent or emergency CD, spinal anesthesia may be appropriate, particularly for patients who have increased risks associated with general anesthesia (ie, known difficult airway, recent oral intake of food, or malignant hyperthermia susceptibility). A single-shot spinal anesthetic by an experienced provider does not take much longer than general anesthesia induction. The anesthesia and obstetric providers should collaborate to determine the degree of urgency so the appropriate anesthetic plan can be formulated.</p><p></p><p class="headingAnchor" id="H3800618628"><span class="h3">Maternal mortality</span><span class="headingEndMark"> — </span>Anesthesia-related mortality during CD is very rare. Based on data from the Pregnancy Mortality Surveillance System, anesthesia-related maternal case fatality rates have changed over time; fatality with general anesthesia has decreased, while fatality associated with regional anesthesia increased from 1979 to 2002 [<a href="#rid23">23</a>]. A review of data from 1997 to 2002, which included 56 deaths, reported a nonsignificant difference in case fatality rates for general anesthesia compared with regional anesthesia during CD (6.5 deaths per million versus 3.8 death per million, risk ratio 1.7, 95% CI 0.6-4.6).</p><p class="headingAnchor" id="H2365706136"><span class="h3">Neonatal effects</span><span class="headingEndMark"> — </span>The literature on the differences in neonatal outcome associated with the choice of anesthetic technique for CD is inconclusive, but the overall effect is likely small. Apgar scores and umbilical acid base status may be affected by variables unrelated to the choice of anesthetic, including the indication for the CD, vasopressors administered during anesthesia (ie, <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> versus <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a>), surgical technical issues, and others. A meta-analysis of 22 randomized studies including 1800 patients who underwent CD reported no difference in umbilical artery or vein pH during non-urgent CD between patients with neuraxial versus general anesthesia [<a href="#rid17">17</a>]. Mean Apgar scores at one minute were higher with epidural than with general anesthesia, with no differences in five-minute Apgar score between general and any type of neuraxial anesthesia.</p><p>Neonatal exposure to anesthetic drugs during induction and maintenance of general anesthesia can cause early neonatal depression. The neonatal resuscitation team should be notified of all medications administered to the mother during induction of general anesthesia, and prior to delivery.</p><p class="headingAnchor" id="H2665888646"><span class="h1">NEURAXIAL ANESTHESIA</span><span class="headingEndMark"> — </span>For CD, a sensory level from sacral dermatomes to T4 is required. </p><p class="headingAnchor" id="H2047013617"><span class="h2">Choice of neuraxial technique</span><span class="headingEndMark"> — </span>Options for neuraxial anesthesia (NA) include single-shot or continuous spinal, epidural, and combined spinal-epidural (CSE). Comparison of these techniques is shown in a table  (<a class="graphic graphic_table graphicRef110997" href="/z/d/graphic/110997.html" rel="external">table 4</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Spinal anesthesia</strong> – Spinal anesthesia is the most commonly used NA technique for CD. Spinal anesthesia is usually performed more quickly than epidural anesthesia and provides rapid onset of dense, bilateral, reliable anesthesia, using a very low dose of drug with minimal risk of maternal toxicity or fetal drug transfer. The duration of anesthesia is limited after single injection spinal, without the ability to extend anesthesia for unforeseen circumstances.</p><p></p><p class="bulletIndent1">Continuous spinal anesthesia (CSA) may be performed to allow slow titration of spinal anesthesia for parturients with some comorbidities (eg, significant cardiac lesions), or for patients in whom epidural placement may be difficult or ineffective for anatomic reasons (eg, patients who have had extensive spinal surgery). CSA is also a reasonable option after an unintentional dural puncture during attempted epidural catheter placement. In obstetric patients, the risk of post dural puncture headache (PDPH) is high when large gauge continuous spinal catheters (18 g or 19 g) are used; this limits the routine use of a continuous spinal. (See  <a class="medical medical_review" href="/z/d/html/105456.html" rel="external">"Spinal anesthesia: Technique", section on 'Continuous spinal'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidural anesthesia</strong> – Epidural anesthesia is a catheter based, continuous technique, such that the onset can be titrated and the duration extended with incremental dosing. Labor epidural analgesia can be converted to a surgical level of epidural anesthesia if necessary and is the preferred technique with a properly working epidural. Epidural anesthesia tends to be less dense and reliable than spinal anesthesia, is less likely to adequately anesthetize sacral levels, and the onset is slower. This technique requires larger doses of drugs, increasing the risk of fetal drug exposure, also increasing the risk of maternal and fetal systemic toxicity if intravascular injection occurs. Therefore, spinal anesthesia is preferred in elective circumstances when a labor epidural is not in place.</p><p></p><p class="bulletIndent1">Some clinicians use dural puncture epidural for anesthesia for CD, particularly in patients with obesity, to help verify the location of the epidural needle tip in the epidural space. (See  <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">"Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'Dural puncture epidural analgesia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Combined spinal–epidural anesthesia </strong>–<strong> </strong>Combined spinal-epidural (CSE) anesthesia provides the rapid onset and other advantages of spinal anesthesia and in addition, the option to extend and prolong anesthesia with the epidural catheter. With this technique, functionality of the epidural catheter is not verified until it is used. However, epidural catheters placed as part of CSE may be at least as reliable, or more so, than standalone epidural catheters [<a href="#rid24">24</a>].</p><p></p><p class="headingAnchor" id="H3428673129"><span class="h2">Spinal anesthesia</span><span class="headingEndMark"> — </span>The techniques for single-shot and continuous spinal anesthesia are described separately. (See  <a class="medical medical_review" href="/z/d/html/105456.html" rel="external">"Spinal anesthesia: Technique"</a>.)</p><p class="headingAnchor" id="H1918283166"><span class="h3">Spinal drugs for CD</span><span class="headingEndMark"> — </span>A combination of local anesthetic (LA) and opioid is usually administered for spinal anesthesia for CD.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Local anesthetics</strong> – <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">Bupivacaine</a> is the most commonly used LA for spinal anesthesia for CD in the United States because of its duration of action appropriate for most CDs, a low incidence of transient radicular irritation, low cost, and wide availability. Other options include <a class="drug drug_general" data-topicid="9873" href="/z/d/drug information/9873.html" rel="external">ropivacaine</a>, levobupivacaine (outside the United States), and <a class="drug drug_general" data-topicid="9245" href="/z/d/drug information/9245.html" rel="external">chloroprocaine</a>  (<a class="graphic graphic_table graphicRef108422" href="/z/d/graphic/108422.html" rel="external">table 5</a>). (See  <a class="medical medical_review" href="/z/d/html/105456.html" rel="external">"Spinal anesthesia: Technique", section on 'Local anesthetics'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Bupivacaine</strong> – Our LA of choice for CD is <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> (hyperbaric 0.75% in 8.25% dextrose), with a usual dose 11 to 12 mg when combined with an opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> and <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a>). The onset time of bupivacaine is five to eight minutes [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Dose range</strong> – The dose range for <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> for spinal anesthesia for CD is from 8 to 12 mg. The 95 percent effective dose (ED95) of intrathecal hyperbaric bupivacaine for CD spinal anesthesia is 11.2 mg [<a href="#rid25">25</a>]. </p><p></p><p class="bulletIndent3">Obesity does not seem to affect the ED95 of hyperbaric <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> for spinal anesthesia for CD [<a href="#rid26">26,27</a>]. However, the ED95 of bupivacaine in extremely obese parturients (ie, with a body mass index [BMI] greater than 50 kg/m<sup>2</sup>) has not been extensively studied. In our practice, we use a CSE technique in patients with a BMI greater than 50 kg<sup>/m2</sup> with a starting intrathecal dose of 9 mg of bupivacaine.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Baricity</strong> – We prefer hyperbaric <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> because of its rapid onset and the option to modify the spinal level by changing the position of the operating table. Plain bupivacaine (ie, slightly hypobaric, prepared in <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a>) may also be used for spinal anesthesia for CD. The literature comparing safety and efficacy of hyperbaric with isobaric bupivacaine for CD is inconclusive [<a href="#rid28">28,29</a>].</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Duration of action</strong> – By 1.5 hours, the midthoracic sensory level will have receded, although total duration of action extends beyond 2.5 hours.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Ropivacaine</strong> – <a class="drug drug_general" data-topicid="9873" href="/z/d/drug information/9873.html" rel="external">Ropivacaine</a> is<strong> </strong>available only in an isobaric formulation. Thus, if a hyperbaric solution is desired, dextrose (5 to 8.25%) must be added. Ropivacaine is approximately 40 percent less potent than <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> [<a href="#rid30">30</a>]. The duration of surgical anesthesia is shorter than bupivacaine [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Dose range – For spinal anesthesia for CD, the typical dose range for <a class="drug drug_general" data-topicid="9873" href="/z/d/drug information/9873.html" rel="external">ropivacaine</a> is from 15 to 20 mg. In a comparative dose finding study, the ED50 (effective dose for 50 percent of patients) and ED90 of intrathecal ropivacaine in patients with singleton pregnancies were 11.2 (95% CI 10.2 - 12.0) mg and 15.7 (95% Ci 14.4 t- 18.3) mg, respectively [<a href="#rid32">32</a>]. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Duration of action – Clinically, at equipotent doses <a class="drug drug_general" data-topicid="9873" href="/z/d/drug information/9873.html" rel="external">ropivacaine</a> provides sensory block equivalent to <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> for CD and may result in more rapid recovery from motor block [<a href="#rid33">33</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chloroprocaine</strong> – <a class="drug drug_general" data-topicid="9245" href="/z/d/drug information/9245.html" rel="external">Chloroprocaine</a> is a short-acting ester LA used at a dose of 45 to 60 mg for spinal anesthesia of short duration (30 to 50 minutes) [<a href="#rid34">34</a>]. Chloroprocaine is of limited use for CD because of its short duration of action [<a href="#rid35">35,36</a>]. (See  <a class="medical medical_review" href="/z/d/html/105456.html" rel="external">"Spinal anesthesia: Technique", section on 'Local anesthetics'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lidocaine</strong> – <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">Lidocaine</a> (60 to 100 mg) is rarely used for spinal anesthesia for CD because of the relatively high risk of transient neurologic symptoms (TNS) in the nonobstetric population. Although there is some evidence that pregnancy and the postpartum period protect against lidocaine-induced TNS [<a href="#rid37">37,38</a>], lidocaine is usually avoided for spinal anesthesia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intrathecal opioids</strong> – Opioids may be added to the LA solution used for spinal anesthesia to improve intraoperative analgesia and for postoperative analgesia. The addition of a lipophilic opioid is particularly helpful for blocking the discomfort of visceral manipulation (eg, manipulation of the uterus during CD). A meta-analysis including over 800 patients who had spinal anesthesia for CD with and without various intrathecal opioids found the need for intraoperative analgesia supplementation decreased from 24 to 4 percent with the addition of opioid to the LA [<a href="#rid39">39</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lipophilic opioids (</strong><a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a><strong> and </strong><a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">sufentanil</a><strong>)</strong> – Lipid-soluble opioids such as fentanyl (10 to 25 mcg) and sufentanil (2.5 to 10 mcg) are commonly added to intrathecal LA to improve intraoperative analgesia [<a href="#rid39">39</a>]. We routinely add fentanyl 15 mcg to <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> for spinal anesthesia for CD. Sufentanil is less commonly used in the United States than in Europe because the concentrated solution (50 mcg/mL) makes accurate measurement of low doses difficult. Lipid-soluble opioids provide minimal postoperative analgesia because of their short duration of action and are not associated with delayed respiratory depression. Pruritus is a common dose-related side effect of intrathecal fentanyl and sufentanil [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent2">A 2020 meta-analysis of 14 randomized trials (700 patients) of the effects of adding <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> to <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> for spinal anesthesia for CD found that intrathecal fentanyl (10 to 15 mcg) reduced the need for supplemental intraoperative analgesia (4.5 percent versus 29.6 percent, RR 0.18, 95% CI 0.11-0.27) and reduced the incidence of intraoperative nausea and vomiting (10 percent versus 25.8 percent, RR 0.41, 95% CI 0.24-0.74) [<a href="#rid41">41</a>]. The incidence of pruritus was increased sixfold with the addition of fentanyl. The results were similar when fentanyl was added to a combination of bupivacaine and <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a>, based on two small trials. The optimal dose of intrathecal fentanyl could not be determined, though doses between 10 and 12.5 mcg reduced the need for intraoperative analgesia and resulted in low rates of intraoperative nausea and vomiting and pruritus. The overall quality of data was judged to be moderate, based on a high risk of bias in some studies.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hydrophilic opioids (</strong><a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a><strong> and </strong><a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">hydromorphone</a><strong>)</strong> – Hydrophilic opioids (eg, preservative-free morphine 75 to 200 mcg or hydromorphone 75 mcg) are commonly added to LA for spinal anesthesia for CD, primarily to provide postoperative analgesia as a component of multimodal opioid sparing postoperative analgesia. Use of neuraxial opioids for post CD analgesia is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/121755.html" rel="external">"Post-cesarean delivery analgesia"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adjuvants</strong> – Additional drugs that may be added to the spinal drug solution include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Epinephrine</strong> – <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">Epinephrine</a> (100 to 200 mcg intrathecal) may be added to intrathecal drugs to prolong the duration of action. In patients who may require longer duration of action in their spinal anesthetic, 100 to 200 mcg of epinephrine can be added. The authors use 100 mcg of intrathecal epinephrine, which extends the surgical block time by 30 to 50 minutes [<a href="#rid42">42</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Clonidine</strong> – Although not commonly used, intrathecal <a class="drug drug_general" data-topicid="9285" href="/z/d/drug information/9285.html" rel="external">clonidine</a> may be of benefit in obstetric patients. Clonidine may be used in addition to or in place of intrathecal opioids in patients with a history of an allergy to opioids, a history of pruritus, substance use disorders or adverse reactions to intrathecal opioids. The addition of clonidine (75 mcg) to hyperbaric <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> improves early postoperative analgesia [<a href="#rid43">43-45</a>], while larger doses (150 mcg) have been reported to decrease hyperalgesia postoperatively [<a href="#rid46">46</a>]. Overall 24-hour opioid consumption does not differ when clonidine is used intrathecally compared with short-acting opioids (eg, <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">sufentanil</a> and <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> [<a href="#rid47">47</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neostigmine</strong> – The use of <a class="drug drug_general" data-topicid="9693" href="/z/d/drug information/9693.html" rel="external">neostigmine</a> in spinal anesthesia has been associated with significant increases in maternal nausea and vomiting and is <strong>not</strong> advised [<a href="#rid48">48</a>].</p><p></p><p class="headingAnchor" id="H1727099675"><span class="h3">Drugs for continuous spinal anesthesia</span><span class="headingEndMark"> — </span>The drugs used for CSA for CD are the same ones used for single-shot spinal. However, dosing must take into account the dead space of the catheter (approximately 0.3 mL, but may vary), and may be reduced if the spinal catheter has been used for labor analgesia. </p><p></p><p class="bulletIndent1">Importantly, inadvertent administration of epidural doses of medications through a spinal catheter can result in high or total spinal anesthesia, severe hypotension, and cardiac arrest. The doses of drugs used for CSA are approximately 10 percent of those that are administered for epidural anesthesia. All members of the nursing, obstetric, and anesthesiology teams must be notified that the catheter is in the intrathecal space, and the catheter should be labeled appropriately.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Spinal catheter placed de novo for CD</strong> – If a de novo spinal catheter is placed, we incrementally administer the spinal <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> to effect (anticipating the same total dose as for a single-shot spinal). We administer the intrathecal adjuncts as a bolus to ensure adequate dosing.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Spinal catheter initially placed for labor analgesia</strong> – When surgical anesthesia is necessary for patients with an in situ spinal catheter for labor analgesia, the initial doses of LA for surgery must be reduced, depending on the labor analgesic infusion, and the patient’s sensory level. Spinal drugs should be administered slowly and titrated to effect. Each labor floor should have a protocol for dosing spinal catheters for emergency CD.</p><p></p><p class="bulletIndent1">The same LA/opioid combination solution used for epidural analgesia may be used for continuous spinal analgesia (eg, <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> 0.0625 to 0.1% or <a class="drug drug_general" data-topicid="9873" href="/z/d/drug information/9873.html" rel="external">ropivacaine</a> 0.08 to 0.1%, either with 2 mcg/mL <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>). The drug delivery mode most commonly used for spinal infusions is the continuous infusion, but the rate must be decreased to 1 to 3 mL/hour, depending on the concentration (eg, 1 mL/hour 0.1% bupivacaine, 3 mL/hour 0.0625% bupivacaine). (See  <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">"Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'Continuous spinal analgesia'</a>.)</p><p></p><p class="bulletIndent1">For emergency CD for these patients, we administer 7.5 mg (1 mL) of 0.75% hyperbaric <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> through the IT catheter. This bolus typically results in adequate anesthesia for surgery; further doses of bupivacaine may be titrated in 1.5 mg increments, to effect. Since in this setting patients have received lipophilic opioid (ie, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> or <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">sufentanil</a>) as part of the infusion for labor analgesia, no additional lipophilic opioid is required for surgical anesthesia. Intrathecal <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a> or <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">hydromorphone</a> should be administered as a bolus for postoperative analgesia. (See  <a class="medical medical_review" href="/z/d/html/121755.html" rel="external">"Post-cesarean delivery analgesia", section on 'Hydrophilic opioids (morphine and hydromorphone)'</a>.) </p><p></p><p class="bulletIndent1">When using an intrathecal catheter, we establish an operative level of anesthesia and then test sensory dermatomes roughly every hour to ensure adequate coverage. If the level is receding prior to the closure of the fascia, we administer incremental supplemental doses of spinal local anesthetic (eg, 3.75 mg or 0.5 mL of hyperbaric 0.75% <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a>) to maintain a T4-T6 level.</p><p></p><p class="headingAnchor" id="H3296859267"><span class="h2">Epidural anesthesia</span><span class="headingEndMark"> — </span>The technique for epidural catheter placement is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/89518.html" rel="external">"Epidural and combined spinal-epidural anesthesia: Techniques", section on 'Epidural anesthesia technique'</a>.)</p><p class="headingAnchor" id="H2933915413"><span class="h3">Epidural drugs for CD</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Local anesthetics </strong>–<strong> </strong>The epidural local anesthetics (LA) commonly used for CD include <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>, <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a>, <a class="drug drug_general" data-topicid="9873" href="/z/d/drug information/9873.html" rel="external">ropivacaine</a>, and in the United States, <a class="drug drug_general" data-topicid="9245" href="/z/d/drug information/9245.html" rel="external">chloroprocaine</a>  (<a class="graphic graphic_table graphicRef113983" href="/z/d/graphic/113983.html" rel="external">table 6</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Choice of LA</strong> – The choice of epidural LA is usually based on the speed of onset required for the clinical situation, and the possibility of systemic toxicity. Our practice is as follows:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For scheduled and non-urgent CD, we typically use 2% <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>. One contributor uses bicarbonated 2% lidocaine with epinephrine in this scenario.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For urgent CD we use bicarbonated 2% <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For emergency CD requiring maximal speed of onset of surgical anesthesia, practice varies among contributors to this topic; one uses bicarbonated 3% 2-choloroprocaine, and another uses bicarbonated 2% <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>. Prior to any rapid epidural medication administration, providers should aspirate the catheter and quickly assess catheter function in an attempt to identify both intrathecal and intravascular migration. </p><p></p><p class="bulletIndent2">The most rapid onset of epidural surgical anesthesia may be achieved by using bicarbonated 3% 2-chloroprocaine; bicarbonated <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> may produce faster onset of epidural anesthesia than 3% 2-chloroprocaine without bicarbonate [<a href="#rid49">49</a>]. </p><p></p><p class="bulletIndent2">In a network meta-analysis of 24 randomized trials that evaluated speed of onset of various epidural local anesthetics for CD, the fastest onset of surgical anesthesia was with bicarbonated 2% <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> [<a href="#rid49">49</a>]. Bicarbonated 3% 2-chloroprocaine was not evaluated. The speed of onset, from fastest to slowest, was with bicarbonated 2% lidocaine &gt; 3% 2-chloroprocaine &gt; 2% lidocaine &gt; 0.75% <a class="drug drug_general" data-topicid="9873" href="/z/d/drug information/9873.html" rel="external">ropivacaine</a> &gt; 0.5% <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a>. The mean onset after bupivacaine 0.5% was 19.8 (95% CI 17.3-22.4) min; compared with bupivacaine, onset after bicarbonated 2% lidocaine, 3% 2‐<a class="drug drug_general" data-topicid="9245" href="/z/d/drug information/9245.html" rel="external">chloroprocaine</a> and 2% lidocaine were 6.4 (95% CI 3.3-9.6), 5.7 (95% CI 3.0-8.3) and 3.9 (95% CI 1.8-6.0) min faster, respectively. Onset after 0.75% ropivacaine was similar to 0.5% bupivacaine. None of the study mixtures contained <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> or opioids.</p><p></p><p class="bulletIndent2">In the network meta-analysis above, the comparison between bicarbonated <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> and <a class="drug drug_general" data-topicid="9245" href="/z/d/drug information/9245.html" rel="external">chloroprocaine</a> was indirect. In a subsequent randomized trial that compared 3% 2-chloroprocaine with a mixture of 2% lidocaine with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>, bicarbonate, and 100 mcg <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>, mean time to onset of surgical anesthesia was modestly faster with the lidocaine mixture, 9.3 versus 10.9 minutes, mean difference 97 seconds (90% CI -10.6 to 204) [<a href="#rid50">50</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lidocaine</strong> – 2% <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> (1:200,000 dilution) is the most commonly used epidural LA for CD. For scheduled cesarean deliveries, and for laboring patients without an epidural catheter in place, 15 to 25 mL of 2% lidocaine with epinephrine (1:200,000) is injected via 5 mL aliquots, after a 3 mL 1.5% lidocaine with epinephrine test dose. (See  <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">"Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'The epidural test dose in obstetrics'</a>.)</p><p></p><p class="bulletIndent2">Approximately 10 to 20 percent less volume and dose of drug are required when converting an existing labor epidural to surgical anesthesia.</p><p></p><p class="bulletIndent2">Onset of anesthesia typically occurs over approximately 5 to 10 minutes; speed of onset can be increased by addition of <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> [<a href="#rid51">51</a>] and/or <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> [<a href="#rid52">52</a>]. In one study, alkalinization of epidural <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> for patients with in situ labor epidural catheters decreased the time from epidural bolus to surgical anesthesia for CD from 9.7 to 5.2 minutes [<a href="#rid51">51</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chloroprocaine</strong><strong> </strong>– 3% 2-chloroprocaine is an LA with the fastest onset and shortest duration of action of LAs available for epidural administration. 2-chloroprocaine is metabolized very rapidly by plasma esterases, and is therefore less likely to cause local anesthetic systemic toxicity than alternative LAs in the event of a catheter inadvertently placed into a blood vessel.</p><p></p><p class="bulletIndent2"><a class="drug drug_general" data-topicid="9245" href="/z/d/drug information/9245.html" rel="external">Chloroprocaine</a> is mainly used for the most urgent cesarean deliveries. The onset of anesthesia with a rapid bolus of 3% 2-chloroprocaine through an existing labor epidural catheter occurs in approximately eight minutes [<a href="#rid53">53</a>] and can be reduced to approximately three minutes with the addition of <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> to the solution [<a href="#rid54">54</a>]. The duration of action, measured as two dermatome regression of sensory block, is approximately 40 to 60 minutes. Therefore, we administer 2% <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> 15 to 20 minutes after chloroprocaine to maintain surgical anesthesia, and administer 5 mL of the lidocaine solution as required at 35 to 50 minute intervals. </p><p></p><p class="bulletIndent2"><a class="drug drug_general" data-topicid="9245" href="/z/d/drug information/9245.html" rel="external">Chloroprocaine</a> may reduce the efficacy of analgesia from subsequently administered epidural <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a> [<a href="#rid55">55,56</a>]. However, we still administer the epidural morphine towards the end of the CD and find it to be clinically effective.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Bupivacaine</strong><strong> </strong>– <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">Bupivacaine</a> is not routinely used for epidural anesthesia for CD because of the risk of cardiac sequelae with intravascular injection, and because of its slow onset. Onset of block occurs in approximately 20 minutes, and the duration of action (two dermatome regression) is 120 to 240 minutes [<a href="#rid52">52</a>]. (See  <a class="medical medical_review" href="/z/d/html/90613.html" rel="external">"Local anesthetic systemic toxicity", section on 'Amide local anesthetics'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Ropivacaine</strong><strong> </strong>–<strong> </strong><a class="drug drug_general" data-topicid="9873" href="/z/d/drug information/9873.html" rel="external">Ropivacaine</a> is also rarely used for CD. Epidural ropivacaine is approximately 40 percent less potent than <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a>, with a similar onset, and slightly shorter duration of action. Therefore, higher doses of ropivacaine than bupivacaine may be required for equivalent anesthesia [<a href="#rid57">57-59</a>]. Ropivacaine may have a higher margin of safety than bupivacaine. However, animal and human studies that have compared cardiotoxicity of the two drugs have reported conflicting results, with some showing cardiac conduction abnormalities at lower doses of bupivacaine than ropivacaine [<a href="#rid60">60-62</a>], and others showing no difference between the two LAs [<a href="#rid61">61,63</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidural opioids</strong> – Opioids may be administered epidurally to speed the onset of anesthesia, improve the quality of the anesthetic, and/or to provide postoperative analgesia [<a href="#rid64">64-66</a>]. Lipophilic opioids (<a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> or <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">sufentanil</a>) are administered primarily for intraoperative analgesia and are administered during initiation of epidural anesthesia. Hydrophilic opioids (ie, <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a> and <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">hydromorphone</a>) are used for postoperative analgesia and are administered after the fetus is delivered. (See  <a class="medical medical_review" href="/z/d/html/121755.html" rel="external">"Post-cesarean delivery analgesia", section on 'Hydrophilic opioids (morphine and hydromorphone)'</a>.) Doses for the commonly used opioids are as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Fentanyl</strong><strong> </strong>–<strong> </strong>50 to 100 mcg [<a href="#rid64">64,65</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sufentanil</strong> – 20 to 30 mcg [<a href="#rid66">66</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Morphine</strong><strong> </strong>– Preservative-free <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a> (1 to 3 mg) should be administered for postoperative analgesia in patients without contraindication during CD. Typical epidural doses range from 1 to 3 mg, with lower doses providing adequate postoperative analgesia for 18 to more than 24 hours with lower incidence of side effects compared with higher doses, when administered as part of a multimodal pain control regimen [<a href="#rid67">67,68</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hydromorphone</strong><strong> </strong>–<strong> </strong>Epidural <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">hydromorphone</a> (0.6 to 1.0 mg) may be a useful alternative for postoperative analgesia when epidural <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a> is not available [<a href="#rid69">69,70</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other adjuvants </strong>–<strong> </strong>Other medications may be added to epidural LA and opioid solutions to improve the anesthetic or speed the onset.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Epinephrine</strong> – <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">Epinephrine</a> (1:400,000 to 1:200,000) is often added to the epidural local anesthetic solution to increase the density of block, reduce systemic absorption of LA, and to prolong the duration of anesthesia [<a href="#rid71">71</a>]. In most cases, a commercially prepared solution of <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> with epinephrine 1:200,000 is used for epidural anesthesia for CD.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neostigmine</strong> – Epidural administration of <a class="drug drug_general" data-topicid="9693" href="/z/d/drug information/9693.html" rel="external">neostigmine</a> may reduce the required dose of LA for CD, and may modestly enhance postoperative analgesia, without significant maternal or fetal side effects [<a href="#rid48">48</a>]. Unlike intrathecal neostigmine, epidural administration does not seem to cause nausea and vomiting.</p><p></p><p class="bulletIndent2"><a class="drug drug_general" data-topicid="9693" href="/z/d/drug information/9693.html" rel="external">Neostigmine</a> is not widely used as an adjunct for epidural anesthesia in the United States and is not used by the authors. Further study is required before recommending the routine use of neostigmine in this setting. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sodium bicarbonate</strong> – <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">Sodium bicarbonate</a> 8.4% may be added to the epidural local anesthetic solution to speed the onset and improve the quality of the block (usually 2 mL/20 mL of local anesthetic). Faster speed of onset with addition of sodium bicarbonate to <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> and to <a class="drug drug_general" data-topicid="9245" href="/z/d/drug information/9245.html" rel="external">chloroprocaine</a> is discussed above. Sodium bicarbonate can be added to <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> only in very small doses (0.1 mL/20 mL); otherwise it will cause precipitation.</p><p></p><p class="headingAnchor" id="H1496370415"><span class="h2">Combined spinal-epidural anesthesia</span><span class="headingEndMark"> — </span>The technique for CSE is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">"Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'CSE technique'</a>.)</p><p>The drugs used for CSE mimic those used for spinal anesthesia and, if necessary, epidural anesthesia. Opioids are added to the spinal drugs (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> and preservative-free <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a>) to directly deliver the drugs to their relevant receptors in the spinal cord. </p><p>There are various options for management of a CSE placed for a scheduled CD, including administration of a full dose of spinal drug, followed by epidural medication as necessary, or administration of a partial spinal dose (ie, sequential CSE) with epidural administration to achieve adequate surgical anesthesia. The authors typically use a full dose spinal technique for CSE.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Full spinal dose CSE</strong> – In most cases, the same initial doses and combinations of spinal drugs are administered as for single-shot spinal anesthesia. The first dose of epidural medication is then administered when the sensory level recedes below T4. At that point, after negative aspiration of the catheter for blood and CSF, we administer a test dose of 3 mL of 1.5 or 2% <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> 1:200,000. In this setting, this bolus acts as a test dose for intravascular injection (ie, tachycardia would occur with intravascular injection of epinephrine). Since the patient already has a spinal block with motor block, the bolus does not test for intrathecal injection. (See  <a class="medical medical_review" href="/z/d/html/101803.html" rel="external">"Neuraxial analgesia for labor and delivery (including instrumental delivery)", section on 'The epidural test dose in obstetrics'</a>.)</p><p></p><p class="bulletIndent1">Therefore, it is always a good practice to fractionate the total dose of local anesthetic (ie, administer 3 to 5 mL at a time).</p><p></p><p class="bulletIndent1">The test dose often reestablishes a level of surgical anesthesia above T4. We then test the sensory level every 20 minutes, and administer aliquots of 3 to 5 mL of 2% <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>, based on the level of the block.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sequential CSE</strong> – A CSE may be managed by injection of a portion of the usual single-shot spinal dose, usually half (eg, 5 to 6 mg <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a>), followed by subsequent epidural injections (eg, 3 to 5 mL of 2% <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>), titrated to achieve adequate surgical anesthesia.</p><p></p><p class="bulletIndent1">Sequential techniques result in less hypotension [<a href="#rid72">72-74</a>] than single-shot or full-dose spinal CSE, and may indicate that the epidural catheter is well positioned at the start of the anesthetic.</p><p></p><p class="headingAnchor" id="H3467994971"><span class="h2">Intraoperative management</span></p><p class="headingAnchor" id="H474795097"><span class="h3">Intraoperative positioning</span><span class="headingEndMark"> — </span>Patients should be positioned with left uterine displacement (LUD) for CD, to minimize the chance of aortocaval compression. (See  <a class="medical medical_review" href="/z/d/html/4475.html" rel="external">"Cesarean birth: Preoperative planning and patient preparation", section on 'Uterine displacement'</a>.)</p><p></p><p>Traditionally, 15 degrees of LUD has been recommended for any pregnant patient with a visibly gravid uterus or at greater than 20 weeks gestational age. The need for and efficacy of LUD for <strong>healthy</strong> parturients have been questioned [<a href="#rid75">75</a>]. Two studies have examined the cardiovascular effects of a 15 degree tilt in patients receiving spinal anesthesia [<a href="#rid76">76,77</a>]. Although these studies failed to demonstrate a difference in neonatal acidosis, both studies utilized aggressive fluid and vasopressor administration, which may have impacted the outcome. In addition, these were healthy parturients without signs of fetal compromise. Therefore, little is known about the effects of 15 degree tilt in parturients whose fetuses may have uteroplacental insufficiency. Both authors of this topic continue to tilt patients when feasible and may employ more aggressive tilting strategies if fetal heart rates are compromised.</p><p class="bulletIndent1"><span class="glyph">●</span>In one study, 100 healthy term parturients with singleton pregnancies were randomly assigned to either a 15 degree left lateral tilt or supine positioning for elective CD with spinal anesthesia [<a href="#rid76">76</a>]. Maternal blood pressure was maintained with intravenous fluid co-loading and <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> infusion targeted at maintaining systolic blood pressure at baseline. There was no difference in neonatal acid base status between the groups. Systolic blood pressures and cardiac output were significantly lower in the supine group, despite increased phenylephrine administration. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another trial, noninvasive cardiac output monitoring was used during spinal anesthesia for CD in 80 healthy parturients who were randomly assigned to supine or 15 degree left lateral tilt positioning [<a href="#rid77">77</a>]. There were no differences in systolic blood pressure, mean arterial pressure, cardiac index, nausea and vomiting, or neonatal Apgar scores between the groups. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A small study compared magnetic resonance imaging (MRI) images of inferior vena cava (IVC) volume during 15 and 30 degrees of left and right lateral tilt in pregnant patients between 31 and 39 weeks gestation [<a href="#rid78">78</a>]. IVC compression was consistently relieved by 30 degrees of left lateral tilt, but not with 15 degrees of left lateral tilt, or with either 15 or 30 degrees of right lateral tilt.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>MRI examination of aortic and IVC volumes in pregnant and nonpregnant peers has shown that IVC volume, but not aortic volume, is influenced by patient position; specifically, a left-lateral tilt of at least 30 degrees is needed to improve vena cava volume [<a href="#rid79">79</a>]. A lateral tilt of 30 degrees is impractical during CD, and further study is required before changing practice. </p><p></p><p class="headingAnchor" id="H62766869"><span class="h3">Supplemental oxygen</span><span class="headingEndMark"> — </span>Most healthy parturients do not require supplemental oxygen during neuraxial anesthesia for uncomplicated CD. We administer supplemental oxygen via facemask or nasal cannulae to parturients with worrisome fetal heart rate tracings and other evidence of fetal compromise, and to parturients with decreased oxygen saturation. </p><p class="headingAnchor" id="H1309363180"><span class="h3">Preventing nausea and vomiting</span><span class="headingEndMark"> — </span>Nausea with or without vomiting occurs commonly during CD with neuraxial anesthesia. We routinely administer prophylaxis for intraoperative and postoperative nausea and vomiting. We administer <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">ondansetron</a> 4 mg IV for prophylaxis for postoperative nausea and vomiting and for hemodynamic benefits in the setting of spinal anesthesia (see <a class="local">'Ondansetron'</a> below). Other options include <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">metoclopramide</a> to facilitate stomach emptying, a <a class="drug drug_general" data-topicid="9915" href="/z/d/drug information/9915.html" rel="external">scopolamine</a> patch (1.5 mg transdermal), and <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">dexamethasone</a> (4 to 8 mg IV). (See  <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">"Postoperative nausea and vomiting", section on 'Antiemetics'</a>.)</p><p>Several etiologies for nausea and vomiting during CD are possible, including the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Hypotension is the most common cause of nausea, and it usually resolves with restoration of normal blood pressure with vasopressors (ie, <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> or <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a>). Prophylactic <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">ondansetron</a> may reduce the incidence of both hypotension and nausea and vomiting induced by spinal anesthesia [<a href="#rid80">80,81</a>]. (See <a class="local">'Vasopressors'</a> below.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Visceral manipulation (eg, uterine exteriorization or reinsertion) may cause nausea despite otherwise adequate neuraxial anesthesia. A small dose of <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> (eg, 25 to 50 mcg IV) often relieves nausea while waiting for completion of surgery.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Uterotonic medication, especially when administered rapidly, can cause nausea. (See  <a class="medical medical_review" href="/z/d/html/5405.html" rel="external">"Cesarean birth: Surgical technique", section on 'Prevention of postpartum hemorrhage'</a>.) </p><p></p><p class="headingAnchor" id="H840431840"><span class="h3">Hemodynamic management</span><span class="headingEndMark"> — </span>Dense neuraxial blockade at the sensory level required for CD (ie, fourth thoracic dermatome) causes sympathetic block and vasodilation, which can result in hypotension if not appropriately treated with vasopressor [<a href="#rid82">82</a>]  (<a class="graphic graphic_figure graphicRef114864" href="/z/d/graphic/114864.html" rel="external">figure 1</a>). </p><p class="headingAnchor" id="H4028037278"><span class="h4">Goal blood pressure</span><span class="headingEndMark"> — </span>We aim to maintain blood pressure within 10 to 20 percent of baseline blood pressure unless the patient has severe hypertension (see  <a class="medical medical_review" href="/z/d/html/94369.html" rel="external">"Anesthesia for the patient with preeclampsia", section on 'Goal blood pressure'</a>). We use a prophylactic <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> infusion as described below, and administer boluses of vasopressors to patients who drop below 20 percent of their baseline blood pressure, to patients who become symptomatic with nausea, vomiting, or lightheadedness, or if the fetus shows signs of distress following placement of spinal anesthesia. (See <a class="local">'Vasopressors'</a> below.)</p><p>While recommendations are usually to maintain systolic blood pressure at ≥100 mmHg or ≥80 percent of baseline for healthy parturients, the optimal goal for blood pressure management has not been defined [<a href="#rid83">83</a>]. A study of approximately 75 parturients who had spinal anesthesia for CD randomly assigned patients to have systolic blood pressure maintained at 80 percent, 90 percent, or 100 percent of baseline value [<a href="#rid84">84</a>]. Blood pressure was controlled by the use of a titrated infusion of <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a>, starting at 100 mcg/min IV, without intravenous preload. Patients whose systolic blood pressure was maintained at 100 percent had significantly less nausea or vomiting compared with the other two groups, and umbilical artery pH was higher, though none of the values were truly acidotic.</p><p class="headingAnchor" id="H1250005142"><span class="h4">Vasopressors</span><span class="headingEndMark"> — </span>Our primary strategy for preventing spinal anesthesia-induced hypotension involves prophylactic, titrated administration of low dose <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> infusion (ie, starting at 25 to 50 mcg/min IV) started around the time of injection of the spinal drug. We administer phenylephrine rescue boluses, aiming for a maternal blood pressure close to baseline. This strategy is largely consistent with the 2017 International Consensus Statement on the Management of Hypotension with Vasopressors During Cesarean Section Under Spinal Anesthesia [<a href="#rid85">85</a>]. A network meta-analysis of 109 randomized trials involving various methods for prevention of spinal hypotension at CD found that vasopressors were more effective than fluid loading, leg compression, or other types of medications [<a href="#rid86">86</a>]. One measure that can be used to temporarily increase venous return while administering vasopressors is to elevate both legs while the patient is in the supine position, with left uterine displacement.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Phenylephrine</strong><strong> versus </strong><strong>ephedrine</strong> – <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">Phenylephrine</a>, a direct, primarily alpha adrenergic agonist and <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a>, an indirect acting alpha and beta adrenergic agonist, are both effective for treating hypotension resulting from spinal anesthesia for healthy parturients at CD [<a href="#rid87">87-91</a>]. Phenylephrine is typically the preferred vasopressor in this situation, although ephedrine may be preferable in some cases (eg, maternal bradycardia). Commonly used doses of vasopressors for treatment of hypotension include phenylephrine (50 to 100 mcg IV bolus, or 25 to 100 mcg/min IV infusion) and ephedrine (5 to 10 mg IV boluses, or infusion, 1 to 5 mg/min IV infusion).</p><p></p><p class="bulletIndent1"><a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">Phenylephrine</a> is associated with a lower incidence of intraoperative nausea and vomiting, and a small but statistically significant increase in umbilical artery pH at delivery, while <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a> may be associated with increased risk of fetal acidosis [<a href="#rid88">88,92-96</a>].</p><p></p><p class="bulletIndent1">It has been suggested that the relative fetal acidosis occurs because <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a> crosses the placenta, increasing fetal metabolic rate. In addition, ephedrine has a delayed onset compared with <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a>, which may result in a longer period of hypotension [<a href="#rid88">88</a>].</p><p></p><p class="bulletIndent1">However, <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> can cause reflex maternal bradycardia; thus, the choice of vasopressor therapy for spinal hypotension is often guided by the resulting maternal heart rate. Profound bradycardia (40 to 50 beats per minute) during phenylephrine infusion should be treated by reducing or stopping the infusion, unless it is accompanied by hypotension. Bradycardia with associated hypotension can be treated with <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a> and may require the use of an anticholinergic medication (<a class="drug drug_general" data-topicid="8496" href="/z/d/drug information/8496.html" rel="external">glycopyrrolate</a>, 0.2 to 0.4 mg IV). </p><p></p><p class="bulletIndent1">In cases of fetal compromise, it is not clear which, if either, vasopressor would be preferable. Most of the studies cited above included healthy parturients undergoing scheduled CD. A retrospective study of approximately 380 high-risk parturients who underwent CD under spinal anesthesia reported no difference in umbilical artery pH in patients who received <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a>, <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a>, or required no vasopressor during the anesthetic [<a href="#rid97">97</a>]. Similarly, a retrospective review of patients with preeclampsia who underwent CD found no difference in umbilical artery pH between patients who received ephedrine and phenylephrine to treat spinal hypotension [<a href="#rid98">98</a>]. In another study in which preeclamptic patients were randomly assigned to prophylactic infusion of phenylephrine or ephedrine during spinal anesthesia for CD, there was no difference in umbilical artery pH between groups [<a href="#rid99">99</a>]. In that study, the range of patients’ baseline systolic blood pressure was from 136 to 162 mmHg. Clinicians should administer prophylactic vasopressors cautiously in patients with preeclampsia, as significant blood pressure elevation may result.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dose of vasopressors</strong> – The optimal doses and method of administration of <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> and <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a> are not clear. Treatment of hypotension with bolus administration of phenylephrine may be associated with more hypotension and intraoperative nausea and vomiting compared with prophylactic infusion, but prophylactic infusion at higher doses (75 to 100 mcg/min) is associated with a higher incidence of bradycardia and hypertension [<a href="#rid87">87,100-103</a>]. Infusions of phenylephrine in patients with hypertensive comorbidities (such as preeclampsia) should be used cautiously. (See  <a class="medical medical_review" href="/z/d/html/94369.html" rel="external">"Anesthesia for the patient with preeclampsia", section on 'Vasopressors during neuraxial analgesia'</a>.)</p><p></p><p class="bulletIndent1">In a 2014 systematic review, administration of a prophylactic <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> infusion (with a fluid load) to parturients having spinal anesthesia decreased the incidence of hypotension by approximately 60 percent before and after delivery (RR = 0.36), and decreased the incidence of nausea and vomiting (RR = 0.39) compared with no prophylaxis or <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a> infusion [<a href="#rid104">104</a>]. There were no differences in other maternal or fetal endpoints or outcomes. Studies available for analysis were limited and included variable dosing regimens.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Norepinephrine</strong> – We do not routinely use <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a> to prevent or treat spinal anesthesia induced hypotension. Limited data suggest that norepinephrine may be as effective as <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> and may cause overall less maternal bradycardia [<a href="#rid105">105-108</a>]. Existing studies have used varied doses and administration protocols; further study is required before recommending routine use of norepinephrine in this setting.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A 2019 meta-analysis of three trials (294 patients) that compared <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a> to <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> for prevention of hypotension after spinal anesthesia for CD found similar hypotension and Apgar scores between groups, and a lower incidence of bradycardia with norepinephrine [<a href="#rid107">107</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a subsequent trial involving 82 parturients who were randomly assigned to receive prophylaxis for spinal induced hypotension with either fixed dose <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a> 4 mcg/minute or <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> 50 mcg/minute, the incidence of bradycardia was lower (4.8 versus 31.7 percent), and fetal pH was slightly higher in the norepinephrine group (7.35 [95% CI 7.33-7.37] versus 7.34 [95% CI 7.26-7.36]) [<a href="#rid108">108</a>]. Apgar scores, the incidence of hypotension, and the use of rescue vasopressors were similar.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In a randomized dose finding study of 99 patients who received intrathecal <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> 10 mg with <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">sufentanil</a> 5 mcg for spinal anesthesia for elective CD, the effective <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a> infusion dose in 50 percent of patients (ED 50) and ED95 for preventing hypotension were 0.029 (95% CI 0.008-0.042) mcg/kg/minute and 0.105 (95% CI 0.082-0.172) mcg/kg/minute, respectively [<a href="#rid105">105</a>]. </p><p></p><p class="bulletIndent1">If used, a reasonable starting dose would be 2.5 to 4 mcg/minute, titrated to effect [<a href="#rid109">109</a>]. Before administration of <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a>, patency of the intravenous catheter should be verified, as extravasation of the drug can result in significant tissue damage.</p><p></p><p class="headingAnchor" id="H3843409066"><span class="h4">Fluid management</span><span class="headingEndMark"> — </span>A rapid bolus of IV crystalloid is usually administered at the time of induction of spinal anesthesia (co-loading), in conjunction with prophylactic and as needed vasopressors. We typically administer a fluid bolus of 500 to 1000 mL IV during the neuraxial procedure, depending on the patient's comorbidities and volume status [<a href="#rid82">82</a>]. Further fluid administration should be based on an accurate estimate of blood loss. In patients with preeclampsia with severe features, a limited fluid bolus should be administered. (See  <a class="medical medical_review" href="/z/d/html/94369.html" rel="external">"Anesthesia for the patient with preeclampsia", section on 'Intravenous fluid management'</a>.)</p><p>Crystalloid solutions are used more commonly than colloid solutions for CD because they are less expensive and more readily available. Furthermore, the available data do not indicate an absolute benefit of colloids over crystalloids [<a href="#rid110">110-114</a>]. </p><p>Glucose-free solutions should be used to prevent hypoglycemia in the fetus. Excessive placental glucose transfer can result in compensatory release of fetal insulin (fetal hyperinsulinemia), resulting in neonatal hypoglycemia after delivery [<a href="#rid115">115,116</a>].</p><p class="headingAnchor" id="H2333632484"><span class="h4">Ondansetron</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">Ondansetron</a> administered at the time of spinal injection may reduce the incidence of spinal hypotension and related symptoms. Two meta-analyses of randomized trials reported that ondansetron administered prophylactically during spinal anesthesia for CD reduced the incidence of hypotension, the dose of vasopressors administered, and the incidence of bradycardia, although the included studies were small with high heterogeneity [<a href="#rid80">80,81</a>]. A randomized trial including 60 patients who underwent elective CD with combined spinal epidural anesthesia found that a single dose of ondansetron 4 mg IV reduced the ED<sub>50</sub> (ie, effective dose in 50 percent of subjects) of <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> infusion by approximately 26 percent [<a href="#rid117">117</a>]. In this study, phenylephrine was administered to maintain blood pressure within 20 percent of baseline.</p><p class="headingAnchor" id="H2035922065"><span class="h3">Maintaining normothermia</span><span class="headingEndMark"> — </span>Similar to other patients having surgical procedures, patients who undergo CD are at risk for hypothermia due to prolonged skin exposure and fluid shifts. Providers should attempt to maintain normothermia in both the mother and the neonate by keeping the room temperature at 22 to 23°C, and using warmed fluids. We cover the mother with warm blankets for routine cesarean deliveries with neuraxial anesthesia of less than an hour duration, and use an active warming device (eg, forced-air warming) for longer procedures and for patients who have general anesthesia. We routinely monitor temperature for patients who have general anesthesia or blood transfusion, and for patients who have neuraxial anesthesia for longer procedures. In non-obstetric patients, intraoperative hypothermia is associated with coagulopathy, infection, prolonged drug effects, and myocardial ischemia, though these outcomes have not been studied in obstetric patients. (See  <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">"Perioperative temperature management", section on 'Consequences'</a>.) </p><p>The optimal methods (eg, prewarming and active intraoperative forced air warming, warmed fluids, increased ambient temperature) for preventing hypothermia during CD are unclear; available literature involves varied interventions and duration of surgery. </p><p class="bulletIndent1"><span class="glyph">●</span>In one study of 30 patients who underwent epidural anesthesia for CD, patients randomly assigned to prewarming and intraoperative warming with an upper body forced air blanket maintained higher core temperature after two hours of surgery than patients who were not actively warmed (37.1 ± 0.4°C versus 36.0 ± 0.5°C) [<a href="#rid118">118</a>]. Newborns of the warmed mothers had higher core temperatures (37.1 ± 0.5 versus 36.2 ± 0.6°C) and higher umbilical vein pH (7.32 ± 0.07 versus 7.24 ± 0.07). Intravenous fluid was warmed to 37°C, and the operating room temperature was kept at 23°C.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In contrast, in a randomized trial that included 30 patients who underwent spinal anesthesia for CD, lower extremity forced air warming did not reduce the incidence of intra- or postoperative hypothermia, defined as core temperature ≤35.5°C (8 of 15 warmed patients, versus 10 of 15 unwarmed) [<a href="#rid119">119</a>]. There were no differences in cord blood gases or neonatal Apgar scores. </p><p></p><p>The mechanisms for perioperative hypothermia, consequences, and preventive measures are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">"Perioperative temperature management"</a>.)</p><p>Neonatal effects of hypothermia are also discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5015.html" rel="external">"Neonatal resuscitation in the delivery room", section on 'Temperature control'</a>.)</p><p class="headingAnchor" id="H3992885687"><span class="h3">Administration of uterotonics</span><span class="headingEndMark"> — </span>Uterine contraction is the main mechanism for reduction of uterine bleeding after delivery. The uterus is massaged, and oxytocin is administered as the first-line uterotonic medication.</p><p>Protocols for infusion of oxytocin vary by institution, but should include either administration of small, slow bolus doses (ie, &lt;3 units intravenous [IV]) or controlled infusion. At one author's institution, oxytocin 18 milliunits/minute IV is started after cord clamping, administered by controlled infusion, and titrated as needed for bleeding up to 36 milliunits/minute.</p><p>Rapid administration of oxytocin can result in hypotension, nausea and vomiting, and chest pain with electrocardiogram changes [<a href="#rid120">120</a>], and can cause cardiovascular collapse [<a href="#rid121">121,122</a>]. The incidence of side effects is directly related to the rate of administration. Therefore, the lowest effective dose of oxytocin should be used. </p><p>The optimal dose and route of administration (ie, bolus dose versus infusion) of oxytocin at CD are unclear. A prospective, double blinded trial randomly assigned 60 patients to receive bolus doses of oxytocin, 3 units over 15 seconds IV, or wide open infusion of oxytocin, during elective CD with spinal anesthesia [<a href="#rid123">123</a>]. Uterine tone was assessed at three minute intervals by the obstetrician, and with additional boluses of oxytocin administered upon request. Patients in the bolus group received less oxytocin to achieve adequate uterine tone compared with those in the infusion group (mean 4 versus 8.4 IU), although there was no difference in systolic or diastolic blood pressure, heart rate, side effects, or blood loss between the two groups.</p><p>If a bolus injection is given after CD, some studies suggest that the addition of an oxytocin infusion reduces delayed blood loss and the need for blood transfusion and/or additional uterotonic agents compared with bolus injection alone [<a href="#rid124">124,125</a>].</p><p>Parturients who receive oxytocin during labor may become desensitized, and require higher doses of oxytocin for a uterotonic effect. In one study, the bolus dose of oxytocin required to achieve adequate uterine tone at CD in 90 percent of patients (ED90) who had received 10 hours of oxytocin in labor was 2.99 (95% CI )2.32-3.67 [<a href="#rid126">126</a>] , compared with an ED90 of 0.35 (95% CI 0.18-0.52) units in patients who underwent elective CD [<a href="#rid127">127</a>]. Similarly, the ED90 for oxytocin infusion is approximately 15 units/hour for elective cesarean deliveries, but this may increase to 44 units/hour in previously laboring patients with oxytocin supplementation [<a href="#rid128">128,129</a>].</p><p>Whether bolus or infusion dosing is used, each unit should have a standardized protocol for oxytocin administration as oxytocin is consistently reported as a high-alert medication by the Institute of Safe Medication Practices and has a narrow therapeutic window. Patients at high risk for bleeding may benefit from prolonged infusions in recovery and postpartum units to reduce the risk of a delayed hemorrhage.</p><p>Other uterotonic medications including <a class="drug drug_general" data-topicid="8562" href="/z/d/drug information/8562.html" rel="external">carbetocin</a> (outside the United States) that are used for postpartum hemorrhage are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6714.html" rel="external">"Postpartum hemorrhage: Medical and minimally invasive management", section on 'Administer additional uterotonic medications'</a>.)</p><p class="headingAnchor" id="H1260876989"><span class="h2">Failed or inadequate neuraxial block</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Inadequate block at initiation</strong> – For elective cesarean deliveries, the level of sensory block should be assessed before skin preparation and draping to allow for supplementation, or if necessary, repeat neuraxial block. A neuraxial block inadequate for surgery may occur if there is no block, a low spinal level, or a patchy block. Management of inadequate block depends on the degree of urgency and patient factors. In urgent situations, general anesthesia should be induced rather than making further attempts at neuraxial anesthesia.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Inadequate spinal anesthesia</strong> – If time permits, 20 minutes should be allowed for full onset of the spinal block before further intervention.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Partial spinal block</strong> – If there is a low or patchy spinal block, we usually place an epidural catheter and titrate the epidural medication to effect, similar to a sequential combined spinal epidural. Repeat single-shot spinal should be avoided, as the correct dose of drug in this scenario cannot be determined, and either high spinal or inadequate spinal is possible. Placement of an epidural catheter and dosing to effect may avoid low or high levels that can occur with repeat spinal administrations. For urgent CD, without time for epidural placement and dosing, general anesthesia should be considered.</p><p></p><p class="bulletIndent3">Alternatively, for scheduled CD, repeat spinal may be performed once all evidence of spinal block has worn off.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>No spinal block</strong> – If after 20 minutes there is no evidence of spinal anesthesia, it is likely safe to repeat full dose spinal anesthesia.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Inadequate epidural anesthesia</strong> – If epidural anesthesia is inadequate for CD after administration of appropriate doses of epidural medications, we replace the epidural catheter and titrate further epidural medication to effect with the new catheter. Single-shot spinal should <strong>not be </strong>performed following failed epidural anesthesia. High block associated with single-shot spinal after failed epidural is one of the most common serious complications of obstetric anesthesia and can result in respiratory arrest [<a href="#rid130">130</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Inadequate block during surgery</strong> – If discomfort occurs during surgery, the level of neuraxial block should be promptly assessed. Additional epidural local anesthetic and/or opioid may be administered if a catheter is in place. Small doses of systemic medication may be effective for anxiolysis or to treat visceral stimulation (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> 50 to 100 mcg IV, <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">midazolam</a> 1 to 2 mg IV, <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a> 10 to 30 mg IV with midazolam pretreatment, <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">nitrous oxide</a> by mask). One contributor to this topic uses intraperitoneal local anesthetic in this setting (ie, 20 mL of 3% 2-chloroprocaine, poured sterilely into the surgical field). However, if the neuraxial block is clearly inadequate despite these maneuvers, then general anesthesia should be induced and the airway secured. </p><p></p><p>The optimal volume and concentration of local anesthetic solution for intraperitoneal instillation and the risk of local anesthetic toxicity have not been determined. In one case series of 32 patients who had pain during CD, 20 to 60 mL of 1% <a class="drug drug_general" data-topicid="9245" href="/z/d/drug information/9245.html" rel="external">chloroprocaine</a> (mean dose 11.8 mg/kg) was poured into the peritoneal cavity after delivery of the fetus [<a href="#rid131">131</a>]. One to five minutes later, excess LA solution was suctioned away. Approximately one-half of the patients had improved pain scores after intraperitoneal LA, though all patients also received intravenous opioids. None of the patients exhibited signs of local anesthetic systemic toxicity (LAST).</p><p class="headingAnchor" id="H4240103728"><span class="h2">High neuraxial block</span><span class="headingEndMark"> — </span>High thoracic levels of spinal or epidural blockade often leads to a subjective feeling of dyspnea. For most patients, reassurance that this is a normal sensation is sufficient. Assessment of grip strength is a quick way to determine whether the block involves the cervical nerve roots, and may be reaching a level that requires ventilatory support. Patients with weak grip strength should be assessed continuously for block progression. In the case of ascending spinal anesthesia with hyperbaric solution, the head of the bed should be elevated to prevent further cephalad spread. If the patient is unable to phonate, or to maintain adequate oxygenation, a rapid sequence induction of general anesthesia with intubation should be performed.</p><p>High neuraxial block may be the most common anesthesia related serious complication in obstetric patients. It can result in respiratory compromise, hypoxemia, hypotension, and cardiac arrest. The Serious Complications Repository Project from the Society for Obstetric Anesthesia and Perinatology collected data on over 250,000 obstetric anesthetics [<a href="#rid130">130</a>]. High neuraxial block was the most frequently reported anesthesia-related complication, and occurred in 1/4336 anesthetics. </p><p>High blocks were associated with both unrecognized intrathecal catheters and with de novo spinal placement following attempted bolusing of an in situ labor epidural catheter that resulted in an inadequate surgical level. Therefore, providers should always aspirate epidural catheters prior to administering medications and bolus catheter medication slowly and incrementally if the clinical situation permits. In addition, if labor epidural catheter fails to adequately provide anesthesia after administration of a large dose of local anesthetics, spinal anesthesia should be avoided as a follow-up technique as this may lead to unusually high or unpredictable levels. (See <a class="local">'Failed or inadequate neuraxial block'</a> above.)</p><p class="headingAnchor" id="H3645840648"><span class="h1">GENERAL ANESTHESIA</span><span class="headingEndMark"> — </span>General anesthesia (GA) may be indicated for CD in certain patient and clinical scenarios. (See <a class="local">'General versus neuraxial anesthesia'</a> above.)</p><p>Patient positioning, hemodynamic management, temperature control, and administration of uterotonic agents during general anesthesia are the same as they are during neuraxial anesthesia. (See <a class="local">'Intraoperative management'</a> above and <a class="local">'Administration of uterotonics'</a> above.)</p><p>Patients who have general anesthesia for CD are at increased risk of difficulty with airway management, and of awareness with recall after anesthesia, compared with non-pregnant patients who undergo other types of surgery.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Airway concerns</strong> – The incidence of airway difficulty and management of the airway for these patients are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/16690.html" rel="external">"Airway management for the pregnant patient"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Awareness during general anesthesia</strong> – Awareness with recall is relatively common during GA for CD. The rate of awareness under anesthesia for obstetric patients may be as high as 1:212, compared with 1:19,600 for all types of surgery [<a href="#rid132">132,133</a>]. The 5<sup>th</sup> National Audit Project from the United Kingdom reported that many of these cases of awareness were preventable.</p><p></p><p class="bulletIndent1">General anesthesia during CD is administered differently than other surgeries due to fetal concerns and maternal physiology; some of the changes in anesthetic technique may contribute to the high incidence of awareness in obstetric patients. Suggested mechanisms for awareness in these patients include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Underdosing or omission of sedative premedication, induction agents, and opioids to avoid placental transfer to the fetus</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Underdosing of inhalation anesthetics to avoid uterine relaxation and bleeding</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Changes in drug distribution related to physiologic changes of pregnancy (eg, increase in cardiac output)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Increase in difficulty with airway management, which is associated with awareness in all patients</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>High percentage of emergencies among patients who have general anesthesia for CD (see  <a class="medical medical_review" href="/z/d/html/400.html" rel="external">"Accidental awareness during general anesthesia"</a>)</p><p></p><p class="bulletIndent1">To minimize the possibility of awareness, we administer a high concentration of volatile anesthetic after induction of anesthesia leading up to delivery, and routinely administer <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">midazolam</a> and opioids after delivery. (See <a class="local">'Maintenance of general anesthesia'</a> below.)</p><p></p><p class="headingAnchor" id="H813768566"><span class="h2">Preparation for general anesthesia</span><span class="headingEndMark"> — </span>Preoperative assessment, intravenous (IV) access, monitoring, and administration of antibiotics are similar whether neuraxial anesthesia or general anesthesia is used. (See <a class="local">'Preparation for anesthesia'</a> above.) </p><p>Prior to general anesthesia, the patient is positioned on the operating table with left uterine displacement, with the head and neck positioned optimally for intubation. The patient's abdomen is typically prepared and draped prior to induction of anesthesia, to minimize the time between induction and delivery and fetal exposure to anesthetics. The surgeon makes an incision only after the anesthesia clinician has the airway secured.</p><p class="headingAnchor" id="H760109143"><span class="h2">Induction of anesthesia</span><span class="headingEndMark"> — </span>Rapid sequence induction and intubation (RSII) is the standard induction technique for CD. RSII and airway management for pregnant patients are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/16690.html" rel="external">"Airway management for the pregnant patient"</a> and  <a class="medical medical_review" href="/z/d/html/94214.html" rel="external">"Rapid sequence induction and intubation (RSII) for anesthesia"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Induction agents</strong> – <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">Propofol</a> (2 to 2.5 mg/kg IV) or <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">etomidate</a> (0.3 to 0.5 mg/kg IV) are the induction agents of choice, although <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a> may be used for hemodynamically unstable or hypovolemic patients. All intravenous induction medications are lipophilic and therefore transfer across the placenta to the fetus. The choice of induction agent should be determined by maternal factors. Since parturients typically do not receive premedication, and have an increased volume of distribution, full induction doses should be administered for general anesthesia. (See  <a class="medical medical_review" href="/z/d/html/94135.html" rel="external">"Induction of general anesthesia: Overview"</a> and  <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adjunctive medications for induction</strong> – For most patients, we avoid administration of intravenous opioids until after the fetus is delivered, though practice varies. In a meta-analysis of 17 randomized placebo controlled studies of the use of <a class="drug drug_general" data-topicid="9347" href="/z/d/drug information/9347.html" rel="external">alfentanil</a>, <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">remifentanil</a>, or <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> during induction of anesthesia for CD, there were no significant differences in Apgar scores at one or five minutes after administration of alfentanil or remifentanil [<a href="#rid134">134</a>]. Based on four studies, fentanyl caused a reduction in five-minute Apgar scores (weighted mean difference [WMD] -0.2), a result that was statistically significant but was likely clinically insignificant. For patients with preeclampsia, opioids and other medications are administered during induction of anesthesia to prevent hypertension with laryngoscopy and intubation. (See  <a class="medical medical_review" href="/z/d/html/94369.html" rel="external">"Anesthesia for the patient with preeclampsia", section on 'Induction of anesthesia'</a>.)</p><p></p><p class="bulletIndent1">We administer adjunct medications, including opioids and vasoactive medications, as indicated by the patient’s medical status. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations"</a> and  <a class="medical medical_review" href="/z/d/html/94369.html" rel="external">"Anesthesia for the patient with preeclampsia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuromuscular blocking agents </strong>–<strong> </strong>A neuromuscular blocking agent (NMBA), typically <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">succinylcholine</a>, is usually administered during induction as part of RSII. (See  <a class="medical medical_review" href="/z/d/html/94214.html" rel="external">"Rapid sequence induction and intubation (RSII) for anesthesia", section on 'Neuromuscular blocking agents (NMBAs)'</a>.)</p><p></p><p class="bulletIndent1">NMBAs do not cross the placenta and are therefore not associated with weakness in the neonate. For routine CD, NMBAs are not required for surgery beyond endotracheal intubation.</p><p></p><p class="headingAnchor" id="H47957203"><span class="h2">Maintenance of general anesthesia</span><span class="headingEndMark"> — </span>After induction and intubation, we administer high-dose volatile anesthetic (eg, <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">sevoflurane</a>, <a class="drug drug_general" data-topicid="8992" href="/z/d/drug information/8992.html" rel="external">isoflurane</a>, <a class="drug drug_general" data-topicid="8891" href="/z/d/drug information/8891.html" rel="external">desflurane</a>) with high flows of oxygen to quickly obtain an adequate end-tidal concentration of anesthetic (1 MAC) and minimize the chance of awareness under anesthesia. </p><p>Volatile inhalation anesthetics produce dose-dependent uterine relaxation [<a href="#rid135">135</a>], which can result in uterine atony and hemorrhage. After delivery, once fetal transfer of medication is no longer a concern, we administer <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">midazolam</a> (2 mg), a short-acting opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> 100 mcg IV), and N<sub>2</sub>O 50 to 70%, to allow a reduced dose of volatile anesthetic to 0.5 to 0.75 MAC or substitute a <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> infusion for the volatile anesthetic. </p><p>Ventilation should be controlled or supported to achieve an end-tidal CO<sub>2</sub> of approximately 30 mmHg, which should correlate with the normal partial pressure of carbon dioxide (PCO<sub>2</sub>) of 30 to 32 mmHg at the end of pregnancy. (See  <a class="medical medical_review" href="/z/d/html/6775.html" rel="external">"Anesthesia for nonobstetric surgery during pregnancy", section on 'Mechanical ventilation'</a>.)</p><p class="headingAnchor" id="H149723148"><span class="h2">Emergence from anesthesia</span><span class="headingEndMark"> — </span>Airway complications in obstetric patients are more common during emergence from anesthesia and the immediate postoperative period than during induction and initial airway management [<a href="#rid136">136</a>]. Emergence and extubation in these patients are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/16690.html" rel="external">"Airway management for the pregnant patient", section on 'Extubation'</a>.)</p><p class="headingAnchor" id="H3731159853"><span class="h1">POST-CESAREAN DELIVERY ANALGESIA</span><span class="headingEndMark"> — </span>Multimodal strategies for postoperative pain control after CD should be used to promote rapid recovery, allow the patient to care for their newborn, and to minimize the need for postoperative opioids. For most patients, the strategy for post-CD pain control should consist of neuraxial opioid and scheduled nonopioid analgesics (<a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a> and nonsteroidal anti-inflammatory drugs [NSAIDs]), with systemic opioids reserved for breakthrough pain. Alternative plans are required for patients who receive general anesthesia for CD and may be required for patients with risk factors for severe postoperative pain (eg, patients with chronic pain and/or who chronically use opioids). Post-CD analgesia is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/121755.html" rel="external">"Post-cesarean delivery analgesia"</a>.)</p><p class="headingAnchor" id="H1893385798"><span class="h1">PATIENTS WITH SUSPECTED OR CONFIRMED COVID-19</span><span class="headingEndMark"> — </span>UpToDate has added information on many aspects of COVID-19, including infection control, airway and other aspects of anesthetic management, intensive care, and obstetric concerns in topic reviews linked at the end of this section. For patients with suspected or confirmed COVID-19, important considerations specific to obstetric anesthesia include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>For elective procedures, screen patients and support persons by phone the night prior to admission to plan necessary resources.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use droplet and contact precautions with eye protection (gown, gloves, mask, face shield) whenever entering a labor room. For operative procedures, regardless of the type of anesthesia, anesthesia clinicians should use droplet, contact, and airborne precautions (gown, gloves, face shield, and N95 mask or powered air purifying respirator [PAPR])</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>COVID-19 is not a contraindication to neuraxial anesthesia. Early epidural analgesia may reduce the need for general anesthesia and airway management should emergency CD become necessary. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with COVID-19 often receive venous thromboembolism prophylaxis. The anticoagulation regimen should be carefully considered so that neuraxial anesthesia techniques may be used. (See  <a class="medical medical_review" href="/z/d/html/14930.html" rel="external">"Neuraxial anesthesia/analgesia techniques in the patient receiving anticoagulant or antiplatelet medication"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Consider checking a platelet count prior to neuraxial anesthesia in symptomatic patients as thrombocytopenia has been reported in both pregnant and nonpregnant patients with severe COVID-19 illness. [<a href="#rid137">137-139</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Although data are limited, performance of an epidural blood patch to treat post dural puncture headache (PDPH) in patients with COVID-19 is likely safe. The theoretical risk of seeding the central nervous system by injecting viremic blood into the epidural space must be weighed against the risk of complications of untreated PDPH, and coagulation status must be considered. </p><p></p><p>Selected UpToDate topic reviews of COVID-19-related issues include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/127481.html" rel="external">"COVID-19: Perioperative risk assessment, preoperative screening and testing, and timing of surgery after infection"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/140910.html" rel="external">"Overview of infection control during anesthetic care", section on 'Infectious agents transmitted by aerosol (eg, COVID-19)'</a>.)</p><p></p><p class="headingAnchor" id="H1580248614"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/129826.html" rel="external">"Society guideline links: Local anesthetic systemic toxicity"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/120196.html" rel="external">"Society guideline links: Post dural puncture headache"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/126613.html" rel="external">"Society guideline links: COVID-19 – Index of guideline topics"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/131710.html" rel="external">"Society guideline links: Obstetric anesthesia"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/122843.html" rel="external">"Society guideline links: Enhanced recovery after surgery"</a>.)</p><p class="headingAnchor" id="H3932377009"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/126982.html" rel="external">"Patient education: Anesthesia for cesarean birth (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H285928114"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative assessment and preparation</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Parturients undergoing cesarean delivery (CD) should have a focused history and physical examination by an anesthesia provider. Antenatal anesthesia consultation should be considered for patients at risk for complications due to preexisting conditions  (<a class="graphic graphic_table graphicRef68666" href="/z/d/graphic/68666.html" rel="external">table 1</a>). (See <a class="local">'Preoperative assessment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients who undergo elective or emergency CD, pharmacologic aspiration prophylaxis should be considered. Options include <a class="drug drug_general" data-topicid="9930" href="/z/d/drug information/9930.html" rel="external">sodium citrate-citric acid</a>, 30 mL orally immediately prior to anesthesia, an H2 receptor antagonist (eg, <a class="drug drug_general" data-topicid="8436" href="/z/d/drug information/8436.html" rel="external">famotidine</a> 20 mg IV) or proton pump inhibitor (eg, <a class="drug drug_general" data-topicid="9474" href="/z/d/drug information/9474.html" rel="external">pantoprazole</a> 40 mg IV) 40 to 60 minutes prior to induction, and <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">metoclopramide</a> 10 mg IV over 1 to 2 minutes, ≥30 minutes prior to induction. (See <a class="local">'Preparation for anesthesia'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Enhanced recovery after cesarean delivery</strong> – Enhanced recovery after cesarean (ERAC) delivery protocols consist of multidisciplinary best practices throughout the perioperative period. Commonly used anesthesia related components of ERAC protocols are shown in a table.  (<a class="graphic graphic_table graphicRef131694" href="/z/d/graphic/131694.html" rel="external">table 3</a>) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Choice of anesthetic technique</strong> – The choice of anesthetic technique for CD should be based on maternal and fetal status, comorbidities, expected duration and difficulty of the procedure, and the presence (or absence) of an in situ epidural catheter. If a working epidural catheter is in place, the epidural catheter is used to achieve surgical anesthesia  (<a class="graphic graphic_algorithm graphicRef131799" href="/z/d/graphic/131799.html" rel="external">algorithm 1</a>). </p><p></p><p class="bulletIndent1">For most patients, we recommend neuraxial anesthesia (NA) rather than general anesthesia (GA) for CD (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). There are exceptions for which GA is more appropriate. While maternal and neonatal outcomes are not clearly improved with NA, most patients prioritize being awake for the birth of the infant. Other theoretical advantages favor NA. (See <a class="local">'General versus neuraxial anesthesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuraxial anesthesia</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For spinal anesthesia, the spinal solution typically includes local anesthetic (LA) (eg, hyperbaric <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> 10 to 12 mg), lipophilic opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> 10 to 25 mcg) to improve intraoperative anesthesia, and hydrophilic opioid (eg, preservative-free <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a> 75 to 200 mcg) for postoperative analgesia. (See <a class="local">'Spinal drugs for CD'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For epidural anesthesia, the epidural solution typically includes LA (eg, 2% <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> 1:200,000 with or without <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a>), lipophilic opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> 50 to 100 mcg) to improve intraoperative anesthesia, and hydrophilic opioid (eg, preservative-free <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a> 1 to 3 mg) for postoperative analgesia. For emergency CD bicarbonated 3% 2-chloroprocaine provides the most rapid onset of surgical anesthesia. (See <a class="local">'Epidural drugs for CD'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Management of failed or inadequate neuraxial anesthesia depends on the urgency of the situation and patient factors. In emergency situations, general anesthesia should be induced. When time permits, neuraxial anesthesia can be performed, taking precautions to avoid high neuraxial block. (See <a class="local">'Failed or inadequate neuraxial block'</a> above and <a class="local">'High neuraxial block'</a> above.). </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Inadequate spinal anesthesia</strong> – If possible, 20 minutes should be allowed after spinal injection to assess full onset. For partial block, we typically place an epidural catheter and titrate to effect. If there is no evidence of block, it is likely safe to repeat full dose spinal.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Inadequate epidural anesthesia</strong> – We replace the epidural catheter and titrate epidural medication to effect. Single-shot spinal should <strong>not</strong> be performed following failed epidural anesthesia, to avoid high neuraxial block. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General anesthesia</strong> – For general anesthesia, our usual strategy is as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We perform rapid sequence induction and intubation. (See <a class="local">'Induction of anesthesia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>After induction, we administer high concentration of volatile anesthetic (eg, <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">sevoflurane</a>, <a class="drug drug_general" data-topicid="8992" href="/z/d/drug information/8992.html" rel="external">isoflurane</a>, or <a class="drug drug_general" data-topicid="8891" href="/z/d/drug information/8891.html" rel="external">desflurane</a>) to rapidly achieve 1 MAC end tidal anesthetic and minimize the risk of awareness during anesthesia. (See <a class="local">'Maintenance of general anesthesia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>After delivery, we administer opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> 100 mcg IV), <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">midazolam</a> 2 mg IV, and <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">nitrous oxide</a> 50 to 70%, and reduce the concentration of volatile anesthetic to 0.5 to 0.75 MAC or substitute a <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> infusion to reduce the risk of uterine atony and hemorrhage.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patient positioning</strong> – Patients should be positioned with left uterine displacement to attempt to avoid aortocaval compression and supine hypotension. (See <a class="local">'Intraoperative positioning'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemodynamic management</strong> – We suggest administration of <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a>, rather than <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a>, to prevent and treat neuraxial block-induced hypotension in the absence of maternal bradycardia (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). For healthy patients, we administer a prophylactic, low dose, titrated infusion of phenylephrine with phenylephrine rescue boluses, along with intravenous volume expansion (co-loading) with glucose free crystalloid solution, with a goal for maternal blood pressure within 20 percent of baseline, and aiming for lack of nausea and vomiting. (See <a class="local">'Hemodynamic management'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Practice Guidelines for Obstetric Anesthesia: An Updated Report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia and the Society for Obstetric Anesthesia and Perinatology. Anesthesiology 2016; 124:270.</a></li><li><a class="nounderline abstract_t">Wong CA, McCarthy RJ, Fitzgerald PC, et al. Gastric emptying of water in obese pregnant women at term. Anesth Analg 2007; 105:751.</a></li><li><a class="nounderline abstract_t">Macfie AG, Magides AD, Richmond MN, Reilly CS. Gastric emptying in pregnancy. Br J Anaesth 1991; 67:54.</a></li><li><a class="nounderline abstract_t">Wong CA, Loffredi M, Ganchiff JN, et al. Gastric emptying of water in term pregnancy. Anesthesiology 2002; 96:1395.</a></li><li><a class="nounderline abstract_t">Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures: An Updated Report by the American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration. Anesthesiology 2017; 126:376.</a></li><li><a class="nounderline abstract_t">Hauptfleisch JJ, Payne KA. An oral sodium citrate-citric acid non-particulate buffer in humans. Br J Anaesth 1996; 77:642.</a></li><li><a class="nounderline abstract_t">Paranjothy S, Griffiths JD, Broughton HK, et al. Interventions at caesarean section for reducing the risk of aspiration pneumonitis. Cochrane Database Syst Rev 2010; :CD004943.</a></li><li><a class="nounderline abstract_t">Frölich MA, Burchfield DJ, Euliano TY, Caton D. A single dose of fentanyl and midazolam prior to Cesarean section have no adverse neonatal effects. Can J Anaesth 2006; 53:79.</a></li><li><a class="nounderline abstract_t">Manouchehrian N, Bakhshaei MH. Nitrous oxide effect on relieving anxiety and pain in parturients under spinal anesthesia for caesarean section. Anesth Pain Med 2014; 4:e16662.</a></li><li><a class="nounderline abstract_t">Wilson RD, Caughey AB, Wood SL, et al. Guidelines for Antenatal and Preoperative care in Cesarean Delivery: Enhanced Recovery After Surgery Society Recommendations (Part 1). Am J Obstet Gynecol 2018; 219:523.e1.</a></li><li><a class="nounderline abstract_t">Caughey AB, Wood SL, Macones GA, et al. Guidelines for intraoperative care in cesarean delivery: Enhanced Recovery After Surgery Society Recommendations (Part 2). Am J Obstet Gynecol 2018; 219:533.</a></li><li><a class="nounderline abstract_t">Sultan P, Sharawi N, Blake L, Carvalho B. Enhanced recovery after caesarean delivery versus standard care studies: a systematic review of interventions and outcomes. Int J Obstet Anesth 2020; 43:72.</a></li><li><a class="nounderline abstract_t">Bollag L, Lim G, Sultan P, et al. Society for Obstetric Anesthesia and Perinatology: Consensus Statement and Recommendations for Enhanced Recovery After Cesarean. Anesth Analg 2021; 132:1362.</a></li><li><a class="nounderline abstract_t">Coffman JC, Fiorini K, Ristev G, et al. Transversus abdominis plane and ilioinguinal/iliohypogastric blocks for cesarean delivery in a patient with type II spinal muscular atrophy. Int J Obstet Anesth 2016; 25:79.</a></li><li><a class="nounderline abstract_t">Mei W, Jin C, Feng L, et al. Bilateral ultrasound-guided transversus abdominis plane block combined with ilioinguinal-iliohypogastric nerve block for cesarean delivery anesthesia. Anesth Analg 2011; 113:134.</a></li><li><a class="nounderline abstract_t">Bucklin BA, Hawkins JL, Anderson JR, Ullrich FA. Obstetric anesthesia workforce survey: twenty-year update. Anesthesiology 2005; 103:645.</a></li><li><a class="nounderline abstract_t">Afolabi BB, Lesi FE. Regional versus general anaesthesia for caesarean section. Cochrane Database Syst Rev 2012; 10:CD004350.</a></li><li><a class="nounderline abstract_t">Heesen M, Hofmann T, Klöhr S, et al. Is general anaesthesia for caesarean section associated with postpartum haemorrhage? Systematic review and meta-analysis. Acta Anaesthesiol Scand 2013; 57:1092.</a></li><li><a class="nounderline abstract_t">Aksoy H, Aksoy Ü, Yücel B, et al. Blood loss in elective cesarean section: is there a difference related to the type of anesthesia? A randomized prospective study. J Turk Ger Gynecol Assoc 2015; 16:158.</a></li><li><a class="nounderline abstract_t">Guglielminotti J, Landau R, Li G. Adverse Events and Factors Associated with Potentially Avoidable Use of General Anesthesia in Cesarean Deliveries. Anesthesiology 2019; 130:912.</a></li><li><a class="nounderline abstract_t">Guglielminotti J, Li G. Exposure to General Anesthesia for Cesarean Delivery and Odds of Severe Postpartum Depression Requiring Hospitalization. Anesth Analg 2020; 131:1421.</a></li><li><a class="nounderline abstract_t">Ismail S, Huda A. An observational study of anaesthesia and surgical time in elective caesarean section: spinal compared with general anaesthesia. Int J Obstet Anesth 2009; 18:352.</a></li><li><a class="nounderline abstract_t">Hawkins JL, Chang J, Palmer SK, et al. Anesthesia-related maternal mortality in the United States: 1979-2002. Obstet Gynecol 2011; 117:69.</a></li><li><a class="nounderline abstract_t">Lee S, Lew E, Lim Y, Sia AT. Failure of augmentation of labor epidural analgesia for intrapartum cesarean delivery: a retrospective review. Anesth Analg 2009; 108:252.</a></li><li><a class="nounderline abstract_t">Ginosar Y, Mirikatani E, Drover DR, et al. ED50 and ED95 of intrathecal hyperbaric bupivacaine coadministered with opioids for cesarean delivery. Anesthesiology 2004; 100:676.</a></li><li><a class="nounderline abstract_t">Carvalho B, Collins J, Drover DR, et al. ED(50) and ED(95) of intrathecal bupivacaine in morbidly obese patients undergoing cesarean delivery. Anesthesiology 2011; 114:529.</a></li><li><a class="nounderline abstract_t">Lee Y, Balki M, Parkes R, Carvalho JC. Dose requirement of intrathecal bupivacaine for cesarean delivery is similar in obese and normal weight women. Rev Bras Anestesiol 2009; 59:674.</a></li><li><a class="nounderline abstract_t">Heng Sia AT, Tan KH, Sng BL, et al. Hyperbaric versus plain bupivacaine for spinal anesthesia for cesarean delivery. Anesth Analg 2015; 120:132.</a></li><li><a class="nounderline abstract_t">Sng BL, Han NLR, Leong WL, et al. Hyperbaric vs. isobaric bupivacaine for spinal anaesthesia for elective caesarean section: a Cochrane systematic review. Anaesthesia 2018; 73:499.</a></li><li><a class="nounderline abstract_t">McDonald SB, Liu SS, Kopacz DJ, Stephenson CA. Hyperbaric spinal ropivacaine: a comparison to bupivacaine in volunteers. Anesthesiology 1999; 90:971.</a></li><li><a class="nounderline abstract_t">Gautier P, De Kock M, Huberty L, et al. Comparison of the effects of intrathecal ropivacaine, levobupivacaine, and bupivacaine for Caesarean section. Br J Anaesth 2003; 91:684.</a></li><li><a class="nounderline abstract_t">Mei Z, Ngan Kee WD, Sheng ZM, et al. Comparative dose-response study of hyperbaric ropivacaine for spinal anesthesia for cesarean delivery in singleton versus twin pregnancies. J Clin Anesth 2020; 67:110068.</a></li><li><a class="nounderline abstract_t">Malhotra R, Johnstone C, Halpern S, et al. Duration of motor block with intrathecal ropivacaine versus bupivacaine for caesarean section: a meta-analysis. Int J Obstet Anesth 2016; 27:9.</a></li><li><a class="nounderline abstract_t">Maes S, Laubach M, Poelaert J. Randomised controlled trial of spinal anaesthesia with bupivacaine or 2-chloroprocaine during caesarean section. Acta Anaesthesiol Scand 2016; 60:642.</a></li><li><a class="nounderline abstract_t">Goldblum E, Atchabahian A. The use of 2-chloroprocaine for spinal anaesthesia. Acta Anaesthesiol Scand 2013; 57:545.</a></li><li><a class="nounderline abstract_t">Hejtmanek MR, Pollock JE. Chloroprocaine for spinal anesthesia: a retrospective analysis. Acta Anaesthesiol Scand 2011; 55:267.</a></li><li><a class="nounderline abstract_t">Philip J, Sharma SK, Gottumukkala VN, et al. Transient neurologic symptoms after spinal anesthesia with lidocaine in obstetric patients. Anesth Analg 2001; 92:405.</a></li><li><a class="nounderline abstract_t">Aouad MT, Siddik SS, Jalbout MI, Baraka AS. Does pregnancy protect against intrathecal lidocaine-induced transient neurologic symptoms? Anesth Analg 2001; 92:401.</a></li><li><a class="nounderline abstract_t">Dahl JB, Jeppesen IS, Jørgensen H, et al. Intraoperative and postoperative analgesic efficacy and adverse effects of intrathecal opioids in patients undergoing cesarean section with spinal anesthesia: a qualitative and quantitative systematic review of randomized controlled trials. Anesthesiology 1999; 91:1919.</a></li><li><a class="nounderline abstract_t">Belzarena SD. Clinical effects of intrathecally administered fentanyl in patients undergoing cesarean section. Anesth Analg 1992; 74:653.</a></li><li><a class="nounderline abstract_t">Uppal V, Retter S, Casey M, et al. Efficacy of Intrathecal Fentanyl for Cesarean Delivery: A Systematic Review and Meta-analysis of Randomized Controlled Trials With Trial Sequential Analysis. Anesth Analg 2020; 130:111.</a></li><li><a class="nounderline abstract_t">Katz D, Hamburger J, Gutman D, et al. The Effect of Adding Subarachnoid Epinephrine to Hyperbaric Bupivacaine and Morphine for Repeat Cesarean Delivery: A Double-Blind Prospective Randomized Control Trial. Anesth Analg 2018; 127:171.</a></li><li><a class="nounderline abstract_t">van Tuijl I, van Klei WA, van der Werff DB, Kalkman CJ. The effect of addition of intrathecal clonidine to hyperbaric bupivacaine on postoperative pain and morphine requirements after Caesarean section: a randomized controlled trial. Br J Anaesth 2006; 97:365.</a></li><li><a class="nounderline abstract_t">Singh R, Gupta D, Jain A. The effect of addition of intrathecal clonidine to hyperbaric bupivacaine on postoperative pain after lower segment caesarean section: A randomized control trial. Saudi J Anaesth 2013; 7:283.</a></li><li><a class="nounderline abstract_t">Crespo S, Dangelser G, Haller G. Intrathecal clonidine as an adjuvant for neuraxial anaesthesia during caesarean delivery: a systematic review and meta-analysis of randomised trials. Int J Obstet Anesth 2017; 32:64.</a></li><li><a class="nounderline abstract_t">Lavand'homme PM, Roelants F, Waterloos H, et al. An evaluation of the postoperative antihyperalgesic and analgesic effects of intrathecal clonidine administered during elective cesarean delivery. Anesth Analg 2008; 107:948.</a></li><li><a class="nounderline abstract_t">Khezri MB, Rezaei M, Delkhosh Reihany M, Haji Seid Javadi E. Comparison of postoperative analgesic effect of intrathecal clonidine and fentanyl added to bupivacaine in patients undergoing cesarean section: a prospective randomized double-blind study. Pain Res Treat 2014; 2014:513628.</a></li><li><a class="nounderline abstract_t">Cossu AP, De Giudici LM, Piras D, et al. A systematic review of the effects of adding neostigmine to local anesthetics for neuraxial administration in obstetric anesthesia and analgesia. Int J Obstet Anesth 2015; 24:237.</a></li><li><a class="nounderline abstract_t">Reschke MM, Monks DT, Varaday SS, et al. Choice of local anaesthetic for epidural caesarean section: a Bayesian network meta-analysis. Anaesthesia 2020; 75:674.</a></li><li><a class="nounderline abstract_t">Sharawi N, Bansal P, Williams M, et al. Comparison of Chloroprocaine Versus Lidocaine With Epinephrine, Sodium Bicarbonate, and Fentanyl for Epidural Extension Anesthesia in Elective Cesarean Delivery: A Randomized, Triple-Blind, Noninferiority Study. Anesth Analg 2021; 132:666.</a></li><li><a class="nounderline abstract_t">Lam DT, Ngan Kee WD, Khaw KS. Extension of epidural blockade in labour for emergency Caesarean section using 2% lidocaine with epinephrine and fentanyl, with or without alkalinisation. Anaesthesia 2001; 56:790.</a></li><li><a class="nounderline abstract_t">Hillyard SG, Bate TE, Corcoran TB, et al. Extending epidural analgesia for emergency Caesarean section: a meta-analysis. Br J Anaesth 2011; 107:668.</a></li><li><a class="nounderline abstract_t">Bjørnestad E, Iversen OL, Raeder J. Similar onset time of 2-chloroprocaine and lidocaine + epinephrine for epidural anesthesia for elective Cesarean section. Acta Anaesthesiol Scand 2006; 50:358.</a></li><li><a class="nounderline abstract_t">Gaiser RR, Cheek TG, Adams HK, Gutsche BB. Epidural lidocaine for cesarean delivery of the distressed fetus. Int J Obstet Anesth 1998; 7:27.</a></li><li><a class="nounderline abstract_t">Karambelkar DJ, Ramanathan S. 2-Chloroprocaine antagonism of epidural morphine analgesia. Acta Anaesthesiol Scand 1997; 41:774.</a></li><li><a class="nounderline abstract_t">Toledo P, McCarthy RJ, Ebarvia MJ, et al. The interaction between epidural 2-chloroprocaine and morphine: a randomized controlled trial of the effect of drug administration timing on the efficacy of morphine analgesia. Anesth Analg 2009; 109:168.</a></li><li><a class="nounderline abstract_t">Lefrant JY, de La Coussaye JE, Ripart J, et al. The comparative electrophysiologic and hemodynamic effects of a large dose of ropivacaine and bupivacaine in anesthetized and ventilated piglets. Anesth Analg 2001; 93:1598.</a></li><li><a class="nounderline abstract_t">Schwoerer AP, Scheel H, Friederich P. A Comparative Analysis of Bupivacaine and Ropivacaine Effects on Human Cardiac SCN5A Channels. Anesth Analg 2015; 120:1226.</a></li><li><a class="nounderline abstract_t">Ngan Kee WD, Ng FF, Khaw KS, et al. Determination and comparison of graded dose-response curves for epidural bupivacaine and ropivacaine for analgesia in laboring nulliparous women. Anesthesiology 2010; 113:445.</a></li><li><a class="nounderline abstract_t">Santos AC, DeArmas PI. Systemic toxicity of levobupivacaine, bupivacaine, and ropivacaine during continuous intravenous infusion to nonpregnant and pregnant ewes. Anesthesiology 2001; 95:1256.</a></li><li><a class="nounderline abstract_t">Dony P, Dewinde V, Vanderick B, et al. The comparative toxicity of ropivacaine and bupivacaine at equipotent doses in rats. Anesth Analg 2000; 91:1489.</a></li><li><a class="nounderline abstract_t">Scott DB, Lee A, Fagan D, et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69:563.</a></li><li><a class="nounderline abstract_t">Feldman HS, Arthur GR, Covino BG. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog. Anesth Analg 1989; 69:794.</a></li><li><a class="nounderline abstract_t">Hong JY, Jee YS, Jeong HJ, et al. Effects of epidural fentanyl on speed and quality of block for emergency cesarean section in extending continuous epidural labor analgesia using ropivacaine and fentanyl. J Korean Med Sci 2010; 25:287.</a></li><li><a class="nounderline abstract_t">Cherng CH, Wong CS, Ho ST. Epidural fentanyl speeds the onset of sensory block during epidural lidocaine anesthesia. Reg Anesth Pain Med 2001; 26:523.</a></li><li><a class="nounderline abstract_t">Vertommen JD, Van Aken H, Vandermeulen E, et al. Maternal and neonatal effects of adding epidural sufentanil to 0.5% bupivacaine for cesarean delivery. J Clin Anesth 1991; 3:371.</a></li><li><a class="nounderline abstract_t">Singh SI, Rehou S, Marmai KL, Jones PM. The efficacy of 2 doses of epidural morphine for postcesarean delivery analgesia: a randomized noninferiority trial. Anesth Analg 2013; 117:677.</a></li><li><a class="nounderline abstract_t">Vora KS, Shah VR, Patel B, et al. Postoperative analgesia with epidural opioids after cesarean section: Comparison of sufentanil, morphine and sufentanil-morphine combination. J Anaesthesiol Clin Pharmacol 2012; 28:491.</a></li><li><a class="nounderline abstract_t">Marroquin B, Feng C, Balofsky A, et al. Neuraxial opioids for post-cesarean delivery analgesia: can hydromorphone replace morphine? A retrospective study. Int J Obstet Anesth 2017; 30:16.</a></li><li><a class="nounderline abstract_t">Halpern SH, Arellano R, Preston R, et al. Epidural morphine vs hydromorphone in post-caesarean section patients. Can J Anaesth 1996; 43:595.</a></li><li><a class="nounderline abstract_t">Sakura S, Sumi M, Morimoto N, Saito Y. The addition of epinephrine increases intensity of sensory block during epidural anesthesia with lidocaine. Reg Anesth Pain Med 1999; 24:541.</a></li><li><a class="nounderline abstract_t">Thorén T, Holmström B, Rawal N, et al. Sequential combined spinal epidural block versus spinal block for cesarean section: effects on maternal hypotension and neurobehavioral function of the newborn. Anesth Analg 1994; 78:1087.</a></li><li><a class="nounderline abstract_t">Fan SZ, Susetio L, Wang YP, et al. Low dose of intrathecal hyperbaric bupivacaine combined with epidural lidocaine for cesarean section--a balance block technique. Anesth Analg 1994; 78:474.</a></li><li><a class="nounderline abstract_t">Choi DH, Ahn HJ, Kim JA. Combined low-dose spinal-epidural anesthesia versus single-shot spinal anesthesia for elective cesarean delivery. Int J Obstet Anesth 2006; 15:13.</a></li><li><a class="nounderline abstract_t">Cluver C, Novikova N, Hofmeyr GJ, Hall DR. Maternal position during caesarean section for preventing maternal and neonatal complications. Cochrane Database Syst Rev 2013; :CD007623.</a></li><li><a class="nounderline abstract_t">Lee AJ, Landau R, Mattingly JL, et al. Left Lateral Table Tilt for Elective Cesarean Delivery under Spinal Anesthesia Has No Effect on Neonatal Acid-Base Status: A Randomized Controlled Trial. Anesthesiology 2017; 127:241.</a></li><li><a class="nounderline abstract_t">Tsai SE, Yeh PH, Hsu PK, et al. Continuous haemodynamic effects of left tilting and supine positions during Caesarean section under spinal anaesthesia with a noninvasive cardiac output monitor system. Eur J Anaesthesiol 2019; 36:72.</a></li><li><a class="nounderline abstract_t">Fujita N, Higuchi H, Sakuma S, et al. Effect of Right-Lateral Versus Left-Lateral Tilt Position on Compression of the Inferior Vena Cava in Pregnant Women Determined by Magnetic Resonance Imaging. Anesth Analg 2019; 128:1217.</a></li><li><a class="nounderline abstract_t">Higuchi H, Takagi S, Zhang K, et al. Effect of lateral tilt angle on the volume of the abdominal aorta and inferior vena cava in pregnant and nonpregnant women determined by magnetic resonance imaging. Anesthesiology 2015; 122:286.</a></li><li><a class="nounderline abstract_t">Gao L, Zheng G, Han J, et al. Effects of prophylactic ondansetron on spinal anesthesia-induced hypotension: a meta-analysis. Int J Obstet Anesth 2015; 24:335.</a></li><li><a class="nounderline abstract_t">Heesen M, Klimek M, Hoeks SE, Rossaint R. Prevention of Spinal Anesthesia-Induced Hypotension During Cesarean Delivery by 5-Hydroxytryptamine-3 Receptor Antagonists: A Systematic Review and Meta-analysis and Meta-regression. Anesth Analg 2016; 123:977.</a></li><li><a class="nounderline abstract_t">Banerjee A, Stocche RM, Angle P, Halpern SH. Preload or coload for spinal anesthesia for elective Cesarean delivery: a meta-analysis. Can J Anaesth 2010; 57:24.</a></li><li><a class="nounderline abstract_t">Klöhr S, Roth R, Hofmann T, et al. Definitions of hypotension after spinal anaesthesia for caesarean section: literature search and application to parturients. Acta Anaesthesiol Scand 2010; 54:909.</a></li><li><a class="nounderline abstract_t">Ngan Kee WD, Khaw KS, Ng FF. Comparison of phenylephrine infusion regimens for maintaining maternal blood pressure during spinal anaesthesia for Caesarean section. Br J Anaesth 2004; 92:469.</a></li><li><a class="nounderline abstract_t">Kinsella SM, Carvalho B, Dyer RA, et al. International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia. Anaesthesia 2018; 73:71.</a></li><li><a class="nounderline abstract_t">Fitzgerald JP, Fedoruk KA, Jadin SM, et al. Prevention of hypotension after spinal anaesthesia for caesarean section: a systematic review and network meta-analysis of randomised controlled trials. Anaesthesia 2020; 75:109.</a></li><li><a class="nounderline abstract_t">Habib AS. A review of the impact of phenylephrine administration on maternal hemodynamics and maternal and neonatal outcomes in women undergoing cesarean delivery under spinal anesthesia. Anesth Analg 2012; 114:377.</a></li><li><a class="nounderline abstract_t">Ngan Kee WD, Khaw KS, Tan PE, et al. Placental transfer and fetal metabolic effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery. Anesthesiology 2009; 111:506.</a></li><li><a class="nounderline abstract_t">Smiley RM. Burden of proof. Anesthesiology 2009; 111:470.</a></li><li><a class="nounderline abstract_t">Lee A, Ngan Kee WD, Gin T. A quantitative, systematic review of randomized controlled trials of ephedrine versus phenylephrine for the management of hypotension during spinal anesthesia for cesarean delivery. Anesth Analg 2002; 94:920.</a></li><li><a class="nounderline abstract_t">Ngan Kee WD, Khaw KS, Lau TK, et al. Randomised double-blinded comparison of phenylephrine vs ephedrine for maintaining blood pressure during spinal anaesthesia for non-elective Caesarean section*. Anaesthesia 2008; 63:1319.</a></li><li><a class="nounderline abstract_t">Veeser M, Hofmann T, Roth R, et al. Vasopressors for the management of hypotension after spinal anesthesia for elective caesarean section. Systematic review and cumulative meta-analysis. Acta Anaesthesiol Scand 2012; 56:810.</a></li><li><a class="nounderline abstract_t">Saravanan S, Kocarev M, Wilson RC, et al. Equivalent dose of ephedrine and phenylephrine in the prevention of post-spinal hypotension in Caesarean section. Br J Anaesth 2006; 96:95.</a></li><li><a class="nounderline abstract_t">Thomas DG, Robson SC, Redfern N, et al. Randomized trial of bolus phenylephrine or ephedrine for maintenance of arterial pressure during spinal anaesthesia for Caesarean section. Br J Anaesth 1996; 76:61.</a></li><li><a class="nounderline abstract_t">Cooper DW, Carpenter M, Mowbray P, et al. Fetal and maternal effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery. Anesthesiology 2002; 97:1582.</a></li><li><a class="nounderline abstract_t">Knigin D, Avidan A, Weiniger CF. The effect of spinal hypotension and anesthesia-to-delivery time interval on neonatal outcomes in planned cesarean delivery. Am J Obstet Gynecol 2020; 223:747.e1.</a></li><li><a class="nounderline abstract_t">Cooper DW, Sharma S, Orakkan P, Gurung S. Retrospective study of association between choice of vasopressor given during spinal anaesthesia for high-risk caesarean delivery and fetal pH. Int J Obstet Anesth 2010; 19:44.</a></li><li><a class="nounderline abstract_t">Ituk US, Cooter M, Habib AS. Retrospective comparison of ephedrine and phenylephrine for the treatment of spinal anesthesia induced hypotension in pre-eclamptic patients. Curr Med Res Opin 2016; 32:1083.</a></li><li><a class="nounderline abstract_t">Higgins N, Fitzgerald PC, van Dyk D, et al. The Effect of Prophylactic Phenylephrine and Ephedrine Infusions on Umbilical Artery Blood pH in Women With Preeclampsia Undergoing Cesarean Delivery With Spinal Anesthesia: A Randomized, Double-Blind Trial. Anesth Analg 2018; 126:1999.</a></li><li><a class="nounderline abstract_t">Ngan Kee WD, Khaw KS, Ng FF, Lee BB. Prophylactic phenylephrine infusion for preventing hypotension during spinal anesthesia for cesarean delivery. Anesth Analg 2004; 98:815.</a></li><li><a class="nounderline abstract_t">Allen TK, George RB, White WD, et al. A double-blind, placebo-controlled trial of four fixed rate infusion regimens of phenylephrine for hemodynamic support during spinal anesthesia for cesarean delivery. Anesth Analg 2010; 111:1221.</a></li><li><a class="nounderline abstract_t">Siddik-Sayyid SM, Taha SK, Kanazi GE, Aouad MT. A randomized controlled trial of variable rate phenylephrine infusion with rescue phenylephrine boluses versus rescue boluses alone on physician interventions during spinal anesthesia for elective cesarean delivery. Anesth Analg 2014; 118:611.</a></li><li><a class="nounderline abstract_t">George RB, McKeen DM, Dominguez JE, et al. A randomized trial of phenylephrine infusion versus bolus dosing for nausea and vomiting during Cesarean delivery in obese women. Can J Anaesth 2018; 65:254.</a></li><li><a class="nounderline abstract_t">Heesen M, Kölhr S, Rossaint R, Straube S. Prophylactic phenylephrine for caesarean section under spinal anaesthesia: systematic review and meta-analysis. Anaesthesia 2014; 69:143.</a></li><li><a class="nounderline abstract_t">Wei C, Qian J, Zhang Y, et al. Norepinephrine for the prevention of spinal-induced hypotension during caesarean delivery under combined spinal-epidural anaesthesia: Randomised, double-blind, dose-finding study. Eur J Anaesthesiol 2020; 37:309.</a></li><li><a class="nounderline abstract_t">Heesen M, Hilber N, Rijs K, et al. A systematic review of phenylephrine vs. noradrenaline for the management of hypotension associated with neuraxial anaesthesia in women undergoing caesarean section. Anaesthesia 2020; 75:800.</a></li><li><a class="nounderline abstract_t">Xu S, Shen X, Liu S, et al. Efficacy and safety of norepinephrine versus phenylephrine for the management of maternal hypotension during cesarean delivery with spinal anesthesia: A systematic review and meta-analysis. Medicine (Baltimore) 2019; 98:e14331.</a></li><li><a class="nounderline abstract_t">Theodoraki K, Hadzilia S, Valsamidis D, Stamatakis E. Prevention of hypotension during elective cesarean section with a fixed-rate norepinephrine infusion versus a fixed-rate phenylephrine infusion. Α double-blinded randomized controlled trial. Int J Surg 2020; 84:41.</a></li><li><a class="nounderline abstract_t">Ngan Kee WD, Lee SWY, Ng FF, Khaw KS. Prophylactic Norepinephrine Infusion for Preventing Hypotension During Spinal Anesthesia for Cesarean Delivery. Anesth Analg 2018; 126:1989.</a></li><li><a class="nounderline abstract_t">Loubert C. Fluid and vasopressor management for Cesarean delivery under spinal anesthesia: continuing professional development. Can J Anaesth 2012; 59:604.</a></li><li><a class="nounderline abstract_t">McDonald S, Fernando R, Ashpole K, Columb M. Maternal cardiac output changes after crystalloid or colloid coload following spinal anesthesia for elective cesarean delivery: a randomized controlled trial. Anesth Analg 2011; 113:803.</a></li><li><a class="nounderline abstract_t">Tawfik MM, Tarbay AI, Elaidy AM, et al. Combined Colloid Preload and Crystalloid Coload Versus Crystalloid Coload During Spinal Anesthesia for Cesarean Delivery: A Randomized Controlled Trial. Anesth Analg 2019; 128:304.</a></li><li><a class="nounderline abstract_t">Chooi C, Cox JJ, Lumb RS, et al. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database Syst Rev 2020; 7:CD002251.</a></li><li><a class="nounderline abstract_t">Park SK, Park DN, Kim YW, et al. Colloid coload versus crystalloid coload to prevent maternal hypotension in women receiving prophylactic phenylephrine infusion during caesarean delivery: a randomised controlled trial. Int J Obstet Anesth 2022; 49:103246.</a></li><li><a class="nounderline abstract_t">Grylack LJ, Chu SS, Scanlon JW. Use of intravenous fluids before cesarean section: effects on perinatal glucose, insulin, and sodium homeostasis. Obstet Gynecol 1984; 63:654.</a></li><li><a class="nounderline abstract_t">Kenepp NB, Kumar S, Shelley WC, et al. Fetal and neonatal hazards of maternal hydration with 5% dextrose before caesarean section. Lancet 1982; 1:1150.</a></li><li><a class="nounderline abstract_t">Xiao F, Wei C, Chang X, et al. A Prospective, Randomized, Double-Blinded Study of the Effect of Intravenous Ondansetron on the Effective Dose in 50% of Subjects of Prophylactic Phenylephrine Infusions for Preventing Spinal Anesthesia-Induced Hypotension During Cesarean Delivery. Anesth Analg 2020; 131:564.</a></li><li><a class="nounderline abstract_t">Horn EP, Schroeder F, Gottschalk A, et al. Active warming during cesarean delivery. Anesth Analg 2002; 94:409.</a></li><li><a class="nounderline abstract_t">Butwick AJ, Lipman SS, Carvalho B. Intraoperative forced air-warming during cesarean delivery under spinal anesthesia does not prevent maternal hypothermia. Anesth Analg 2007; 105:1413.</a></li><li><a class="nounderline abstract_t">Jonsson M, Hanson U, Lidell C, Nordén-Lindeberg S. ST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial. BJOG 2010; 117:76.</a></li><li><a class="nounderline abstract_t">May A. The Confidential Enquiries into Maternal Deaths 1997-1999: what can we learn? Int J Obstet Anesth 2002; 11:153.</a></li><li><a class="nounderline abstract_t">Langesaeter E, Rosseland LA, Stubhaug A. Haemodynamic effects of repeated doses of oxytocin during Caesarean delivery in healthy parturients. Br J Anaesth 2009; 103:260.</a></li><li><a class="nounderline abstract_t">Kovacheva VP, Soens MA, Tsen LC. A Randomized, Double-blinded Trial of a "Rule of Threes" Algorithm versus Continuous Infusion of Oxytocin during Elective Cesarean Delivery. Anesthesiology 2015; 123:92.</a></li><li><a class="nounderline abstract_t">Güngördük K, Asicioglu O, Celikkol O, et al. Use of additional oxytocin to reduce blood loss at elective caesarean section: A randomised control trial. Aust N Z J Obstet Gynaecol 2010; 50:36.</a></li><li><a class="nounderline abstract_t">Sheehan SR, Montgomery AA, Carey M, et al. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial. BMJ 2011; 343:d4661.</a></li><li><a class="nounderline abstract_t">Balki M, Ronayne M, Davies S, et al. Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet Gynecol 2006; 107:45.</a></li><li><a class="nounderline abstract_t">Carvalho JC, Balki M, Kingdom J, Windrim R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol 2004; 104:1005.</a></li><li><a class="nounderline abstract_t">George RB, McKeen D, Chaplin AC, McLeod L. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery. Can J Anaesth 2010; 57:578.</a></li><li><a class="nounderline abstract_t">Lavoie A, McCarthy RJ, Wong CA. The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study. Anesth Analg 2015; 121:159.</a></li><li><a class="nounderline abstract_t">D'Angelo R, Smiley RM, Riley ET, Segal S. Serious complications related to obstetric anesthesia: the serious complication repository project of the Society for Obstetric Anesthesia and Perinatology. Anesthesiology 2014; 120:1505.</a></li><li><a class="nounderline abstract_t">Werntz M, Burwick R, Togioka B. Intraperitoneal chloroprocaine is a useful adjunct to neuraxial block during cesarean delivery: a case series. Int J Obstet Anesth 2018; 35:33.</a></li><li><a class="nounderline abstract_t">Pandit JJ, Andrade J, Bogod DG, et al. 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors. Br J Anaesth 2014; 113:549.</a></li><li><a class="nounderline abstract_t">Odor PM, Bampoe S, Lucas DN, et al. Incidence of accidental awareness during general anaesthesia in obstetrics: a multicentre, prospective cohort study. Anaesthesia 2021; 76:759.</a></li><li><a class="nounderline abstract_t">White LD, Hodsdon A, An GH, et al. Induction opioids for caesarean section under general anaesthesia: a systematic review and meta-analysis of randomised controlled trials. Int J Obstet Anesth 2019; 40:4.</a></li><li><a class="nounderline abstract_t">Yoo KY, Lee JC, Yoon MH, et al. The effects of volatile anesthetics on spontaneous contractility of isolated human pregnant uterine muscle: a comparison among sevoflurane, desflurane, isoflurane, and halothane. Anesth Analg 2006; 103:443.</a></li><li><a class="nounderline abstract_t">Mhyre JM, Riesner MN, Polley LS, Naughton NN. A series of anesthesia-related maternal deaths in Michigan, 1985-2003. Anesthesiology 2007; 106:1096.</a></li><li><a class="nounderline abstract_t">Kim JH, Shrestha N, Girshin M. Unexpected Severe Thrombocytopenia in the COVID-19 Positive Parturient. Anesth Analg 2020; 131:e116.</a></li><li><a class="nounderline abstract_t">Bauer ME, Chiware R, Pancaro C. Neuraxial Procedures in COVID-19-Positive Parturients: A Review of Current Reports. Anesth Analg 2020; 131:e22.</a></li><li><a class="nounderline abstract_t">Le Gouez A, Vivanti AJ, Benhamou D, et al. Thrombocytopenia in pregnant patients with mild COVID-19. Int J Obstet Anesth 2020; 44:13.</a></li></ol></div><div id="topicVersionRevision">Topic 4480 Version 98.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26580836" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Practice Guidelines for Obstetric Anesthesia: An Updated Report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia and the Society for Obstetric Anesthesia and Perinatology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17717235" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Gastric emptying of water in obese pregnant women at term.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1859760" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Gastric emptying in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12170052" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Gastric emptying of water in term pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28045707" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures: An Updated Report by the American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8957982" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : An oral sodium citrate-citric acid non-particulate buffer in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20091567" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Interventions at caesarean section for reducing the risk of aspiration pneumonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16371613" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : A single dose of fentanyl and midazolam prior to Cesarean section have no adverse neonatal effects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24977119" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Nitrous oxide effect on relieving anxiety and pain in parturients under spinal anesthesia for caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30240657" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Guidelines for Antenatal and Preoperative care in Cesarean Delivery: Enhanced Recovery After Surgery Society Recommendations (Part 1).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30118692" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Guidelines for intraoperative care in cesarean delivery: Enhanced Recovery After Surgery Society Recommendations (Part 2).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32299662" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Enhanced recovery after caesarean delivery versus standard care studies: a systematic review of interventions and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33177330" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Society for Obstetric Anesthesia and Perinatology: Consensus Statement and Recommendations for Enhanced Recovery After Cesarean.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26597404" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Transversus abdominis plane and ilioinguinal/iliohypogastric blocks for cesarean delivery in a patient with type II spinal muscular atrophy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21467562" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Bilateral ultrasound-guided transversus abdominis plane block combined with ilioinguinal-iliohypogastric nerve block for cesarean delivery anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16129992" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Obstetric anesthesia workforce survey: twenty-year update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23076903" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Regional versus general anaesthesia for caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24003971" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Is general anaesthesia for caesarean section associated with postpartum haemorrhage? Systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26401109" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Blood loss in elective cesarean section: is there a difference related to the type of anesthesia? A randomized prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30789362" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Adverse Events and Factors Associated with Potentially Avoidable Use of General Anesthesia in Cesarean Deliveries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33079866" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Exposure to General Anesthesia for Cesarean Delivery and Odds of Severe Postpartum Depression Requiring Hospitalization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19699631" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : An observational study of anaesthesia and surgical time in elective caesarean section: spinal compared with general anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21173646" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Anesthesia-related maternal mortality in the United States: 1979-2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19095859" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Failure of augmentation of labor epidural analgesia for intrapartum cesarean delivery: a retrospective review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15108985" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : ED50 and ED95 of intrathecal hyperbaric bupivacaine coadministered with opioids for cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21307769" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : ED(50) and ED(95) of intrathecal bupivacaine in morbidly obese patients undergoing cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20011857" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Dose requirement of intrathecal bupivacaine for cesarean delivery is similar in obese and normal weight women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25625258" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Hyperbaric versus plain bupivacaine for spinal anesthesia for cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29044483" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Hyperbaric vs. isobaric bupivacaine for spinal anaesthesia for elective caesarean section: a Cochrane systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10201665" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Hyperbaric spinal ropivacaine: a comparison to bupivacaine in volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14570791" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Comparison of the effects of intrathecal ropivacaine, levobupivacaine, and bupivacaine for Caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32980764" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Comparative dose-response study of hyperbaric ropivacaine for spinal anesthesia for cesarean delivery in singleton versus twin pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27106206" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Duration of motor block with intrathecal ropivacaine versus bupivacaine for caesarean section: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26608876" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Randomised controlled trial of spinal anaesthesia with bupivacaine or 2-chloroprocaine during caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23320599" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The use of 2-chloroprocaine for spinal anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21288208" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Chloroprocaine for spinal anesthesia: a retrospective analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11159241" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Transient neurologic symptoms after spinal anesthesia with lidocaine in obstetric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11159240" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Does pregnancy protect against intrathecal lidocaine-induced transient neurologic symptoms?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10598635" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Intraoperative and postoperative analgesic efficacy and adverse effects of intrathecal opioids in patients undergoing cesarean section with spinal anesthesia: a qualitative and quantitative systematic review of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1567031" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Clinical effects of intrathecally administered fentanyl in patients undergoing cesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30633056" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Efficacy of Intrathecal Fentanyl for Cesarean Delivery: A Systematic Review and Meta-analysis of Randomized Controlled Trials With Trial Sequential Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29077615" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The Effect of Adding Subarachnoid Epinephrine to Hyperbaric Bupivacaine and Morphine for Repeat Cesarean Delivery: A Double-Blind Prospective Randomized Control Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16861258" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The effect of addition of intrathecal clonidine to hyperbaric bupivacaine on postoperative pain and morphine requirements after Caesarean section: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24015131" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The effect of addition of intrathecal clonidine to hyperbaric bupivacaine on postoperative pain after lower segment caesarean section: A randomized control trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28823524" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Intrathecal clonidine as an adjuvant for neuraxial anaesthesia during caesarean delivery: a systematic review and meta-analysis of randomised trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18713912" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : An evaluation of the postoperative antihyperalgesic and analgesic effects of intrathecal clonidine administered during elective cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24649361" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Comparison of postoperative analgesic effect of intrathecal clonidine and fentanyl added to bupivacaine in patients undergoing cesarean section: a prospective randomized double-blind study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26119258" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : A systematic review of the effects of adding neostigmine to local anesthetics for neuraxial administration in obstetric anesthesia and analgesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31867718" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Choice of local anaesthetic for epidural caesarean section: a Bayesian network meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32852294" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Comparison of Chloroprocaine Versus Lidocaine With Epinephrine, Sodium Bicarbonate, and Fentanyl for Epidural Extension Anesthesia in Elective Cesarean Delivery: A Randomized, Triple-Blind, Noninferiority Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11493247" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Extension of epidural blockade in labour for emergency Caesarean section using 2% lidocaine with epinephrine and fentanyl, with or without alkalinisation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21997149" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Extending epidural analgesia for emergency Caesarean section: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16480471" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Similar onset time of 2-chloroprocaine and lidocaine + epinephrine for epidural anesthesia for elective Cesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15321243" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Epidural lidocaine for cesarean delivery of the distressed fetus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9241341" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : 2-Chloroprocaine antagonism of epidural morphine analgesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19535707" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The interaction between epidural 2-chloroprocaine and morphine: a randomized controlled trial of the effect of drug administration timing on the efficacy of morphine analgesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11726452" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The comparative electrophysiologic and hemodynamic effects of a large dose of ropivacaine and bupivacaine in anesthetized and ventilated piglets.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25692452" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : A Comparative Analysis of Bupivacaine and Ropivacaine Effects on Human Cardiac SCN5A Channels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20613484" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Determination and comparison of graded dose-response curves for epidural bupivacaine and ropivacaine for analgesia in laboring nulliparous women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11684998" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Systemic toxicity of levobupivacaine, bupivacaine, and ropivacaine during continuous intravenous infusion to nonpregnant and pregnant ewes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11094006" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : The comparative toxicity of ropivacaine and bupivacaine at equipotent doses in rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2679230" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Acute toxicity of ropivacaine compared with that of bupivacaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2511782" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20119585" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Effects of epidural fentanyl on speed and quality of block for emergency cesarean section in extending continuous epidural labor analgesia using ropivacaine and fentanyl.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11707790" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Epidural fentanyl speeds the onset of sensory block during epidural lidocaine anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1834099" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Maternal and neonatal effects of adding epidural sufentanil to 0.5% bupivacaine for cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23921652" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : The efficacy of 2 doses of epidural morphine for postcesarean delivery analgesia: a randomized noninferiority trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23225931" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Postoperative analgesia with epidural opioids after cesarean section: Comparison of sufentanil, morphine and sufentanil-morphine combination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28185794" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Neuraxial opioids for post-cesarean delivery analgesia: can hydromorphone replace morphine? A retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8773867" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Epidural morphine vs hydromorphone in post-caesarean section patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10588559" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : The addition of epinephrine increases intensity of sensory block during epidural anesthesia with lidocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8198262" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Sequential combined spinal epidural block versus spinal block for cesarean section: effects on maternal hypotension and neurobehavioral function of the newborn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8109762" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Low dose of intrathecal hyperbaric bupivacaine combined with epidural lidocaine for cesarean section--a balance block technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16256330" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Combined low-dose spinal-epidural anesthesia versus single-shot spinal anesthesia for elective cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23543552" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Maternal position during caesarean section for preventing maternal and neonatal complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28598894" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Left Lateral Table Tilt for Elective Cesarean Delivery under Spinal Anesthesia Has No Effect on Neonatal Acid-Base Status: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30520787" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Continuous haemodynamic effects of left tilting and supine positions during Caesarean section under spinal anaesthesia with a noninvasive cardiac output monitor system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31094791" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Effect of Right-Lateral Versus Left-Lateral Tilt Position on Compression of the Inferior Vena Cava in Pregnant Women Determined by Magnetic Resonance Imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25603203" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Effect of lateral tilt angle on the volume of the abdominal aorta and inferior vena cava in pregnant and nonpregnant women determined by magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26421701" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Effects of prophylactic ondansetron on spinal anesthesia-induced hypotension: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27537930" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Prevention of Spinal Anesthesia-Induced Hypotension During Cesarean Delivery by 5-Hydroxytryptamine-3 Receptor Antagonists: A Systematic Review and Meta-analysis and Meta-regression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19859776" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Preload or coload for spinal anesthesia for elective Cesarean delivery: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20455872" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Definitions of hypotension after spinal anaesthesia for caesarean section: literature search and application to parturients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14977792" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Comparison of phenylephrine infusion regimens for maintaining maternal blood pressure during spinal anaesthesia for Caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29090733" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31531852" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Prevention of hypotension after spinal anaesthesia for caesarean section: a systematic review and network meta-analysis of randomised controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22104076" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : A review of the impact of phenylephrine administration on maternal hemodynamics and maternal and neonatal outcomes in women undergoing cesarean delivery under spinal anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19672175" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Placental transfer and fetal metabolic effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19672174" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Burden of proof.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11916798" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : A quantitative, systematic review of randomized controlled trials of ephedrine versus phenylephrine for the management of hypotension during spinal anesthesia for cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19032300" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Randomised double-blinded comparison of phenylephrine vs ephedrine for maintaining blood pressure during spinal anaesthesia for non-elective Caesarean section*.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22313496" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Vasopressors for the management of hypotension after spinal anesthesia for elective caesarean section. Systematic review and cumulative meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16311286" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Equivalent dose of ephedrine and phenylephrine in the prevention of post-spinal hypotension in Caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8672382" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Randomized trial of bolus phenylephrine or ephedrine for maintenance of arterial pressure during spinal anaesthesia for Caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12459688" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Fetal and maternal effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32791121" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : The effect of spinal hypotension and anesthesia-to-delivery time interval on neonatal outcomes in planned cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19945278" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Retrospective study of association between choice of vasopressor given during spinal anaesthesia for high-risk caesarean delivery and fetal pH.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26928367" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Retrospective comparison of ephedrine and phenylephrine for the treatment of spinal anesthesia induced hypotension in pre-eclamptic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28953494" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : The Effect of Prophylactic Phenylephrine and Ephedrine Infusions on Umbilical Artery Blood pH in Women With Preeclampsia Undergoing Cesarean Delivery With Spinal Anesthesia: A Randomized, Double-Blind Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14980943" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Prophylactic phenylephrine infusion for preventing hypotension during spinal anesthesia for cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20495139" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : A double-blind, placebo-controlled trial of four fixed rate infusion regimens of phenylephrine for hemodynamic support during spinal anesthesia for cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24299932" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : A randomized controlled trial of variable rate phenylephrine infusion with rescue phenylephrine boluses versus rescue boluses alone on physician interventions during spinal anesthesia for elective cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29209926" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : A randomized trial of phenylephrine infusion versus bolus dosing for nausea and vomiting during Cesarean delivery in obese women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24588024" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Prophylactic phenylephrine for caesarean section under spinal anaesthesia: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31977628" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Norepinephrine for the prevention of spinal-induced hypotension during caesarean delivery under combined spinal-epidural anaesthesia: Randomised, double-blind, dose-finding study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32012226" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : A systematic review of phenylephrine vs. noradrenaline for the management of hypotension associated with neuraxial anaesthesia in women undergoing caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30702617" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Efficacy and safety of norepinephrine versus phenylephrine for the management of maternal hypotension during cesarean delivery with spinal anesthesia: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33080415" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Prevention of hypotension during elective cesarean section with a fixed-rate norepinephrine infusion versus a fixed-rate phenylephrine infusion.Αdouble-blinded randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28678073" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Prophylactic Norepinephrine Infusion for Preventing Hypotension During Spinal Anesthesia for Cesarean Delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22528166" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Fluid and vasopressor management for Cesarean delivery under spinal anesthesia: continuing professional development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21890886" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Maternal cardiac output changes after crystalloid or colloid coload following spinal anesthesia for elective cesarean delivery: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29461392" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Combined Colloid Preload and Crystalloid Coload Versus Crystalloid Coload During Spinal Anesthesia for Cesarean Delivery: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32619039" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Techniques for preventing hypotension during spinal anaesthesia for caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35012809" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Colloid coload versus crystalloid coload to prevent maternal hypotension in women receiving prophylactic phenylephrine infusion during caesarean delivery: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6371625" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Use of intravenous fluids before cesarean section: effects on perinatal glucose, insulin, and sodium homeostasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6122939" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Fetal and neonatal hazards of maternal hydration with 5% dextrose before caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31725021" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : A Prospective, Randomized, Double-Blinded Study of the Effect of Intravenous Ondansetron on the Effective Dose in 50% of Subjects of Prophylactic Phenylephrine Infusions for Preventing Spinal Anesthesia-Induced Hypotension During Cesarean Delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11812709" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Active warming during cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17959975" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Intraoperative forced air-warming during cesarean delivery under spinal anesthesia does not prevent maternal hypothermia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19781043" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : ST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15321539" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : The Confidential Enquiries into Maternal Deaths 1997-1999: what can we learn?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19502285" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Haemodynamic effects of repeated doses of oxytocin during Caesarean delivery in healthy parturients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25909969" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : A Randomized, Double-blinded Trial of a "Rule of Threes" Algorithm versus Continuous Infusion of Oxytocin during Elective Cesarean Delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20218995" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Use of additional oxytocin to reduce blood loss at elective caesarean section: A randomised control trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21807773" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16394038" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Minimum oxytocin dose requirement after cesarean delivery for labor arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15516392" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Oxytocin requirements at elective cesarean delivery: a dose-finding study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20238255" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25902327" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24845921" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Serious complications related to obstetric anesthesia: the serious complication repository project of the Society for Obstetric Anesthesia and Perinatology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29502993" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Intraperitoneal chloroprocaine is a useful adjunct to neuraxial block during cesarean delivery: a case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25204697" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33434945" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Incidence of accidental awareness during general anaesthesia in obstetrics: a multicentre, prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31230994" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Induction opioids for caesarean section under general anaesthesia: a systematic review and meta-analysis of randomised controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16861431" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : The effects of volatile anesthetics on spontaneous contractility of isolated human pregnant uterine muscle: a comparison among sevoflurane, desflurane, isoflurane, and halothane.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17525583" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : A series of anesthesia-related maternal deaths in Michigan, 1985-2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32371745" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Unexpected Severe Thrombocytopenia in the COVID-19 Positive Parturient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32221171" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Neuraxial Procedures in COVID-19-Positive Parturients: A Review of Current Reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32673964" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Thrombocytopenia in pregnant patients with mild COVID-19.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
